1
|
Park JH, Lee ES, Jung YJ. Functional characterization of the DNA-binding protein from starved cells (DPS) as a molecular chaperone under heat stress. Biochem Biophys Res Commun 2023; 667:180-185. [PMID: 37229826 DOI: 10.1016/j.bbrc.2023.05.064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Accepted: 05/18/2023] [Indexed: 05/27/2023]
Abstract
The DNA-binding protein from starved cells, known as DPS, has been characterized as a crucial factor in protecting E. coli from external stresses. The DPS functions in various cellular processes, including protein-DNA binding, ferroxidase activity, compaction of chromosome and regulation of stress resistance gene expression. DPS proteins exist as oligomeric complexes; however, the specific biochemical activity of oligomeric DPS in conferring heat shock tolerance has not been fully understood. Therefore, we investigated the novel functional role of DPS under heat shock. To elucidate the functional role of DPS under heat shock conditions, we purified recombinant GST-DPS protein and demonstrated its thermostability and existence in its highly oligomeric form. Furthermore, we discovered that the hydrophobic region of GST-DPS influenced the formation of oligomers, which exhibited molecular chaperone activity, thereby preventing the aggregation of substrate proteins. Collectively, our findings highlight the novel functional role of DPS, as a molecular chaperone and may confer thermotolerance to E. coli.
Collapse
Affiliation(s)
- Joung Hun Park
- Division of Ecological Safety, National Institute of Ecology, Seocheon, Republic of Korea
| | - Eun Seon Lee
- Division of Ecological Safety, National Institute of Ecology, Seocheon, Republic of Korea
| | - Young Jun Jung
- Division of Ecological Safety, National Institute of Ecology, Seocheon, Republic of Korea.
| |
Collapse
|
2
|
Lee ES, Kiuchi Y, Inomata N, Sueki H. Increased expression of human herpes virus 6 receptor CD134/OX40 in skin lesions of patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. J Dermatol 2023; 50:387-392. [PMID: 36121111 DOI: 10.1111/1346-8138.16575] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Revised: 08/18/2022] [Accepted: 08/23/2022] [Indexed: 11/30/2022]
Abstract
CD134/OX40, a member of the tumor necrosis factor receptor superfamily, is a cell-specific receptor for human herpesvirus 6 (HHV-6) variant B. Patients with drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS) present a significant increase in CD134 expression in peripheral blood CD4+ T cells. We aimed to investigate the frequency of CD134+ CD4 T cells infiltrating skin lesions in patients with DIHS/DRESS and its association with disease severity. We retrospectively included 21 patients with DIHS/DRESS and 11 patients with erythema multiforme (EM). By immunohistochemistry, the frequency of CD134+ CD4 T cells in DIHS was significantly higher than that in EM (p = 0.0083). The DIHS/DRESS severity score was significantly correlated with the frequency of CD134+ CD4 T cells (p = 0.0272); moreover, there was a significant difference between severe and mild/moderate cases. Double immunofluorescence staining revealed that numerous cells presented CD134/CD4 and CD134/Foxp3 overlap in patients with DIHS/DRESS. These data suggest increased susceptibility to HHV-6 infection at localized skin sites. HHV-6 may be involved in the mechanism underlying the progression and pathophysiology of DIHS/DRESS.
Collapse
Affiliation(s)
- Eun Seon Lee
- Departments of Dermatology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan.,Departments of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan
| | - Yuji Kiuchi
- Departments of Pharmacology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan
| | - Naoko Inomata
- Departments of Dermatology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan
| | - Hirohiko Sueki
- Departments of Dermatology, Showa University School of Medicine, Shinagawa-ku, Tokyo, Japan
| |
Collapse
|
3
|
Lee ES, Park JH, Wi SD, Kang CH, Chi YH, Chae HB, Paeng SK, Ji MG, Kim WY, Kim MG, Yun DJ, Stacey G, Lee SY. Author Correction: Redox-dependent structural switch and CBF activation confer freezing tolerance in plants. Nat Plants 2022; 8:1493. [PMID: 36376505 DOI: 10.1038/s41477-022-01285-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Affiliation(s)
- Eun Seon Lee
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Joung Hun Park
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Seong Dong Wi
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Chang Ho Kang
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Yong Hun Chi
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Ho Byoung Chae
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Seol Ki Paeng
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Myung Geun Ji
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Woe-Yeon Kim
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Min Gab Kim
- College of Pharmacy, Gyeongsang National University, Jinju, Korea
| | - Dae-Jin Yun
- Department of Biomedical Science & Engineering, Konkuk University, Seoul, Korea
| | - Gary Stacey
- Divisions of Plant Science and Biochemistry, University of Missouri, Columbia, MO, USA
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea.
- College of Life Sciences, Qingdao Agricultural University, Qingdao, China.
| |
Collapse
|
4
|
Sunaga Y, Hama N, Ochiai H, Kokaze A, Lee ES, Watanabe H, Kurosawa M, Azukizawa H, Asada H, Watanabe Y, Yamaguchi Y, Aihara M, Mizukawa Y, Ohyama M, Abe R, Hashizume H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Takahashi H, Mieno H, Ueta M, Sotozono C, Niihara H, Morita E, Sueki H. Risk factors for sepsis and effects of pretreatment with systemic steroid therapy for underlying condition in SJS/TEN patients: Results of a nationwide cross-sectional survey in 489 Japanese patients. J Dermatol Sci 2022; 107:75-81. [DOI: 10.1016/j.jdermsci.2022.07.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2022] [Revised: 06/23/2022] [Accepted: 07/10/2022] [Indexed: 11/27/2022]
|
5
|
Phan KAT, Paeng SK, Chae HB, Park JH, Lee ES, Wi SD, Bae SB, Kim MG, Yun D, Kim W, Lee SY. Universal Stress Protein (
USP
) regulates the circadian rhythm of central oscillator genes in
Arabidopsis. FEBS Lett 2022; 596:1871-1880. [DOI: 10.1002/1873-3468.14410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2022] [Accepted: 05/18/2022] [Indexed: 11/08/2022]
Affiliation(s)
- Kieu Anh Thi Phan
- Division of Applied Life Science (BK21+) and PMBBRC, 2College of Pharmacy Gyeongsang National University Jinju, 52828 Korea
| | - Seol Ki Paeng
- Division of Applied Life Science (BK21+) and PMBBRC, 2College of Pharmacy Gyeongsang National University Jinju, 52828 Korea
| | - Ho Byoung Chae
- Division of Applied Life Science (BK21+) and PMBBRC, 2College of Pharmacy Gyeongsang National University Jinju, 52828 Korea
| | - Joung Hun Park
- Division of Applied Life Science (BK21+) and PMBBRC, 2College of Pharmacy Gyeongsang National University Jinju, 52828 Korea
| | - Eun Seon Lee
- Division of Applied Life Science (BK21+) and PMBBRC, 2College of Pharmacy Gyeongsang National University Jinju, 52828 Korea
| | - Seong Dong Wi
- Division of Applied Life Science (BK21+) and PMBBRC, 2College of Pharmacy Gyeongsang National University Jinju, 52828 Korea
| | - Su Bin Bae
- Division of Applied Life Science (BK21+) and PMBBRC, 2College of Pharmacy Gyeongsang National University Jinju, 52828 Korea
| | | | - Dae‐Jin Yun
- Department of Biomedical Science & Engineering Konkuk University Seoul, 05029 Korea
| | - Woe‐Yeon Kim
- Division of Applied Life Science (BK21+) and PMBBRC, 2College of Pharmacy Gyeongsang National University Jinju, 52828 Korea
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21+) and PMBBRC, 2College of Pharmacy Gyeongsang National University Jinju, 52828 Korea
| |
Collapse
|
6
|
Wi SD, Lee ES, Park JH, Chae HB, Paeng SK, Bae SB, Phan TKA, Kim WY, Yun DJ, Lee SY. Redox-mediated structural and functional switching of C-repeat binding factors enhances plant cold tolerance. New Phytol 2022; 233:1067-1073. [PMID: 34537981 DOI: 10.1111/nph.17745] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/24/2021] [Accepted: 08/12/2021] [Indexed: 06/13/2023]
Abstract
C-repeat binding factors (CBFs) are key cold-responsive transcription factors that play pleiotropic roles in the cold acclimation, growth, and development of plants. Cold-sensitive cbf knockout mutants and cold-tolerant CBF overexpression lines exhibit abnormal phenotypes at warm temperatures, suggesting that CBF activity is precisely regulated, and a critical threshold level must be maintained for proper plant growth under normal conditions. Cold-inducible CBFs also exist in warm-climate plants but as inactive disulfide-bonded oligomers. However, upon translocation to the nucleus under a cold snap, the h2-isotype of cytosolic thioredoxin (Trx-h2), reduces the oxidized (inactive) CBF oligomers and the newly synthesized CBF monomers, thus producing reduced (active) CBF monomers. Thus, the redox-dependent structural switching and functional activation of CBFs protect plants under cold stress.
Collapse
Affiliation(s)
- Seong Dong Wi
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, 52828, Korea
| | - Eun Seon Lee
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, 52828, Korea
| | - Joung Hun Park
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, 52828, Korea
| | - Ho Byoung Chae
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, 52828, Korea
| | - Seol Ki Paeng
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, 52828, Korea
| | - Su Bin Bae
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, 52828, Korea
| | - Thi Kieu Anh Phan
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, 52828, Korea
| | - Woe-Yeon Kim
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, 52828, Korea
| | - Dae-Jin Yun
- Department of Biomedical Science & Engineering, Konkuk University, Seoul, 05029, Korea
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, 52828, Korea
| |
Collapse
|
7
|
Lee ES, McHenry A, Siddon A, Tormey C. Renal allograft rejection with thrombotic microangiopathy associated with a Kidd blood group system alloantibody. Am J Clin Pathol 2021. [DOI: 10.1093/ajcp/aqab191.340] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction/Objective
The Kidd blood group antigens are urea transporters found on the surface of red blood cells, renal tubular epithelial cells, and endothelial cells in the renal medulla and vasa recta. While controversial, some reports have described an association between Kidd antigen donor/recipient mismatches and kidney transplant rejection when recipients possess or form anti-Kidd alloantibodies. To date, none of these reports have described development of a thrombotic microangiopathy (TMA) in the renal graft associated with these antibodies. We describe a case of fulminant renal transplant rejection associated with TMA in a patient with anti-Jk(a) alloantibodies who received a deceased-donor kidney transplant (DDKT).
Methods/Case Report
A 64-year-old woman with end-stage renal disease secondary to AL amyloidosis caused by plasma cell neoplasm received a DDKT associated with delayed graft function. No pre- or post-transplant donor specific antibodies (DSA) were detected, the flow crossmatch testing was negative, and a pre-operative type and screen identified anti-Jk(a) alloantibodies. On post-transplant day 5, her creatinine remained elevated at 6 mg/dL (ref range: 0.4–1.3 mg/dL) with an acute drop in platelets and undetectable haptoglobin. Allograft biopsy showed a combination of TMA with some additional evidence of acute cellular rejection. Tacrolimus was stopped to rule out drug-induced TMA, and the workup showed negative Shiga toxin, normal ADAMTS13 activity, negative atypical HUS genetic testing, and negative antiphospholipid syndrome testing. Genotyping of the donor kidney was positive for the Jk(a) antigen. Eculizumab, IVIG, and a trial of 8 sessions of therapeutic plasma exchange (TPE) were administered. Her creatinine improved (1.93–2.05 mg/dL), indicating a significant antibody-mediated etiology to her delayed graft function. About one month later, her creatinine worsened, and she received another trial of TPE with IVIG and eculizumab. Despite a mild decrease in her creatinine, repeat biopsies showed acute cellular rejection, persistent TMA, and chronic allograft injury. No DSAs were ever detected. Her creatinine never recovered, and she is now dialysis-dependent.
Results (if a Case Study enter NA)
NA
Conclusion
We speculate that anti-Jk(a) antibodies interacting with a Jk(a)-positive donor kidney account for graft TMA. This case underscores the potential importance of matching Kidd antigens in kidney transplantation.
Collapse
Affiliation(s)
- E S Lee
- Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, UNITED STATES
| | - A McHenry
- Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, UNITED STATES
| | - A Siddon
- Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, UNITED STATES
| | - C Tormey
- Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, UNITED STATES
| |
Collapse
|
8
|
Kang CH, Lee ES, Nawkar GM, Park JH, Wi SD, Bae SB, Chae HB, Paeng SK, Hong JC, Lee SY. Constitutive Photomorphogenic 1 Enhances ER Stress Tolerance in Arabidopsis. Int J Mol Sci 2021; 22:ijms221910772. [PMID: 34639112 PMCID: PMC8509555 DOI: 10.3390/ijms221910772] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2021] [Revised: 10/01/2021] [Accepted: 10/02/2021] [Indexed: 11/26/2022] Open
Abstract
Interaction between light signaling and stress response has been recently reported in plants. Here, we investigated the role of CONSTITUTIVE PHOTOMORPHOGENIC 1 (COP1), a key regulator of light signaling, in endoplasmic reticulum (ER) stress response in Arabidopsis. The cop1-4 mutant Arabidopsis plants were highly sensitive to ER stress induced by treatment with tunicarmycin (Tm). Interestingly, the abundance of nuclear-localized COP1 increased under ER stress conditions. Complementation of cop1-4 mutant plants with the wild-type or variant types of COP1 revealed that the nuclear localization and dimerization of COP1 are essential for its function in plant ER stress response. Moreover, the protein amount of ELONGATED HYPOCOTYL 5 (HY5), which inhibits bZIP28 to activate the unfolded protein response (UPR), decreased under ER stress conditions in a COP1-dependent manner. Accordingly, the binding of bZIP28 to the BIP3 promoter was reduced in cop1-4 plants and increased in hy5 plants compared with the wild type. Furthermore, introduction of the hy5 mutant locus into the cop1-4 mutant background rescued its ER stress-sensitive phenotype. Altogether, our results suggest that COP1, a negative regulator of light signaling, positively controls ER stress response by partially degrading HY5 in the nucleus.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Jong Chan Hong
- Correspondence: (J.C.H.); (S.Y.L.); Tel.: +82-55-772-1353 (J.C.H.); +82-55-772-1351 (S.Y.L.); Fax: +82-55-759-9363
| | - Sang Yeol Lee
- Correspondence: (J.C.H.); (S.Y.L.); Tel.: +82-55-772-1353 (J.C.H.); +82-55-772-1351 (S.Y.L.); Fax: +82-55-759-9363
| |
Collapse
|
9
|
Lee ES, Park JH, Wi SD, Chae HB, Paeng SK, Bae SB, Phan KAT, Kim MG, Kwak SS, Kim WY, Yun DJ, Lee SY. Demyristoylation of the Cytoplasmic Redox Protein Trx-h2 Is Critical for Inducing a Rapid Cold Stress Response in Plants. Antioxidants (Basel) 2021; 10:antiox10081287. [PMID: 34439534 PMCID: PMC8389195 DOI: 10.3390/antiox10081287] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2021] [Revised: 08/09/2021] [Accepted: 08/11/2021] [Indexed: 12/27/2022] Open
Abstract
In Arabidopsis, the cytosolic redox protein thioredoxin h2 (Trx-h2) is anchored to the cytoplasmic endomembrane through the myristoylated second glycine residue (Gly2). However, under cold stress, the cytosolic Trx-h2 is rapidly translocated to the nucleus, where it interacts with and reduces the cold-responsive C-repeat-binding factors (CBFs), thus activating cold-responsive (COR) genes. In this study, we investigated the significance of fatty acid modification of Trx-h2 under cold conditions by generating transgenic Arabidopsis lines in the trx-h2 mutant background, overexpressing Trx-h2 (Trx-h2OE/trx-h2) and its point mutation variant Trx-h2(G/A) [Trx-h2(G/A)OE/trx-h2], in which the Gly2 was replaced by alanine (Ala). Due to the lack of Gly2, Trx-h2(G/A) was incapable of myristoylation, and a part of Trx-h2(G/A) localized to the nucleus even under warm temperature. As no time is spent on the demyristoylation and subsequent nuclear translocation of Trx-h2(G/A) under a cold snap, the ability of Trx-h2(G/A) to protect plants from cold stress was greater than that of Trx-h2. Additionally, COR genes were up-regulated earlier in Trx-h2(G/A)2OE/trx-h2 plants than in Trx-h2OE/trx-h2 plants under cold stress. Consequently, Trx-h2(G/A)2OE/trx-h2 plants showed greater cold tolerance than Col-0 (wild type) and Trx-h2OE/trx-h2 plants. Overall, our results clearly demonstrate the significance of the demyristoylation of Trx-h2 in enhancing plant cold/freezing tolerance.
Collapse
Affiliation(s)
- Eun Seon Lee
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; (E.S.L.); (J.H.P.); (S.D.W.); (H.B.C.); (S.K.P.); (S.B.B.); (K.A.T.P.); (W.-Y.K.)
| | - Joung Hun Park
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; (E.S.L.); (J.H.P.); (S.D.W.); (H.B.C.); (S.K.P.); (S.B.B.); (K.A.T.P.); (W.-Y.K.)
| | - Seong Dong Wi
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; (E.S.L.); (J.H.P.); (S.D.W.); (H.B.C.); (S.K.P.); (S.B.B.); (K.A.T.P.); (W.-Y.K.)
| | - Ho Byoung Chae
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; (E.S.L.); (J.H.P.); (S.D.W.); (H.B.C.); (S.K.P.); (S.B.B.); (K.A.T.P.); (W.-Y.K.)
| | - Seol Ki Paeng
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; (E.S.L.); (J.H.P.); (S.D.W.); (H.B.C.); (S.K.P.); (S.B.B.); (K.A.T.P.); (W.-Y.K.)
| | - Su Bin Bae
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; (E.S.L.); (J.H.P.); (S.D.W.); (H.B.C.); (S.K.P.); (S.B.B.); (K.A.T.P.); (W.-Y.K.)
| | - Kieu Anh Thi Phan
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; (E.S.L.); (J.H.P.); (S.D.W.); (H.B.C.); (S.K.P.); (S.B.B.); (K.A.T.P.); (W.-Y.K.)
| | - Min Gab Kim
- College of Pharmacy, Gyeongsang National University, Jinju 52828, Korea;
| | - Sang-Soo Kwak
- Plant Systems Engineering Research Center, KRIBB, Daejeon 34141, Korea;
| | - Woe-Yeon Kim
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; (E.S.L.); (J.H.P.); (S.D.W.); (H.B.C.); (S.K.P.); (S.B.B.); (K.A.T.P.); (W.-Y.K.)
| | - Dae-Jin Yun
- Department of Biomedical Science & Engineering, Konkuk University, Seoul 05029, Korea;
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; (E.S.L.); (J.H.P.); (S.D.W.); (H.B.C.); (S.K.P.); (S.B.B.); (K.A.T.P.); (W.-Y.K.)
- Correspondence: ; Tel.: +82-55-772-1351; Fax: +82-55-759-9363
| |
Collapse
|
10
|
Chae HB, Kim MG, Kang CH, Park JH, Lee ES, Lee SU, Chi YH, Paeng SK, Bae SB, Wi SD, Yun BW, Kim WY, Yun DJ, Mackey D, Lee SY. Redox sensor QSOX1 regulates plant immunity by targeting GSNOR to modulate ROS generation. Mol Plant 2021; 14:1312-1327. [PMID: 33962063 DOI: 10.1016/j.molp.2021.05.004] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Revised: 02/25/2021] [Accepted: 05/03/2021] [Indexed: 05/22/2023]
Abstract
Reactive oxygen signaling regulates numerous biological processes, including stress responses in plants. Redox sensors transduce reactive oxygen signals into cellular responses. Here, we present biochemical evidence that a plant quiescin sulfhydryl oxidase homolog (QSOX1) is a redox sensor that negatively regulates plant immunity against a bacterial pathogen. The expression level of QSOX1 is inversely correlated with pathogen-induced reactive oxygen species (ROS) accumulation. Interestingly, QSOX1 both senses and regulates ROS levels by interactingn with and mediating redox regulation of S-nitrosoglutathione reductase, which, consistent with previous findings, influences reactive nitrogen-mediated regulation of ROS generation. Collectively, our data indicate that QSOX1 is a redox sensor that negatively regulates plant immunity by linking reactive oxygen and reactive nitrogen signaling to limit ROS production.
Collapse
Affiliation(s)
- Ho Byoung Chae
- Division of Applied Life Sciences (BK21) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea
| | - Min Gab Kim
- College of Pharmacy, Research Institute of Pharmaceutical Science, Gyeongsang National University, Jinju 52828, Korea
| | - Chang Ho Kang
- Division of Applied Life Sciences (BK21) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea
| | - Joung Hun Park
- Division of Applied Life Sciences (BK21) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea
| | - Eun Seon Lee
- Division of Applied Life Sciences (BK21) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea
| | - Sang-Uk Lee
- School of Applied Biosciences, College of Agriculture and Life Sciences, Kyungpook National University, Daegu 41566, Korea
| | - Yong Hun Chi
- Plant Propagation Team, Plant Production Division, Sejong National Arboretum, Sejong 30106, Korea
| | - Seol Ki Paeng
- Division of Applied Life Sciences (BK21) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea
| | - Su Bin Bae
- Division of Applied Life Sciences (BK21) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea
| | - Seong Dong Wi
- Division of Applied Life Sciences (BK21) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea
| | - Byung-Wook Yun
- School of Applied Biosciences, College of Agriculture and Life Sciences, Kyungpook National University, Daegu 41566, Korea
| | - Woe-Yeon Kim
- Division of Applied Life Sciences (BK21) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea
| | - Dae-Jin Yun
- Department of Biomedical Science and Engineering, Konkuk University, Seoul 05029, Korea
| | - David Mackey
- Department of Horticulture and Crop Science, Department of Molecular Genetics, and Center for Applied Plant Sciences, The Ohio State University, Columbus, OH 43210, USA.
| | - Sang Yeol Lee
- Division of Applied Life Sciences (BK21) and PMBBRC, Gyeongsang National University, Jinju 52828, Korea; College of Life Sciences, Qingdao Agricultural University, Qingdao 266109, P.R. China.
| |
Collapse
|
11
|
Lee ES, Park JH, Wi SD, Kang CH, Chi YH, Chae HB, Paeng SK, Ji MG, Kim WY, Kim MG, Yun DJ, Stacey G, Lee SY. Redox-dependent structural switch and CBF activation confer freezing tolerance in plants. Nat Plants 2021; 7:914-922. [PMID: 34155371 DOI: 10.1038/s41477-021-00944-8] [Citation(s) in RCA: 48] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2020] [Accepted: 05/12/2021] [Indexed: 05/20/2023]
Abstract
The activities of cold-responsive C-repeat-binding transcription factors (CBFs) are tightly controlled as they not only induce cold tolerance but also regulate normal plant growth under temperate conditions1-4. Thioredoxin h2 (Trx-h2)-a cytosolic redox protein identified as an interacting partner of CBF1-is normally anchored to cytoplasmic endomembranes through myristoylation at the second glycine residue5,6. However, after exposure to cold conditions, the demyristoylated Trx-h2 is translocated to the nucleus, where it reduces the oxidized (inactive) CBF oligomers and monomers. The reduced (active) monomers activate cold-regulated gene expression. Thus, in contrast to the Arabidopsis trx-h2 (AT5G39950) null mutant, Trx-h2 overexpression lines are highly cold tolerant. Our findings reveal the mechanism by which cold-mediated redox changes induce the structural switching and functional activation of CBFs, therefore conferring plant cold tolerance.
Collapse
Affiliation(s)
- Eun Seon Lee
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Joung Hun Park
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Seong Dong Wi
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Chang Ho Kang
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Yong Hun Chi
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Ho Byoung Chae
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Seol Ki Paeng
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Myung Geun Ji
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Woe-Yeon Kim
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea
| | - Min Gab Kim
- College of Pharmacy, Gyeongsang National University, Jinju, Korea
| | - Dae-Jin Yun
- Department of Biomedical Science & Engineering, Konkuk University, Seoul, Korea
| | - Gary Stacey
- Divisions of Plant Science and Biochemistry, University of Missouri, Columbia, MO, USA
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21+) and PMBBRC, Gyeongsang National University, Jinju, Korea.
- College of Life Sciences, Qingdao Agricultural University, Qingdao, China.
| |
Collapse
|
12
|
Park JH, Lee ES, Chae HB, Paeng SK, Wi SD, Bae SB, Thi Phan KA, Lee SY. Disulfide reductase activity of thioredoxin-h2 imparts cold tolerance in Arabidopsis. Biochem Biophys Res Commun 2021; 568:124-130. [PMID: 34217011 DOI: 10.1016/j.bbrc.2021.06.081] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2021] [Accepted: 06/23/2021] [Indexed: 02/02/2023]
Abstract
Many thioredoxin-h (Trx-h) proteins, cytosolic isotypes of Trxs, have been functionally characterized in plants; however, the physiological function of Arabidopsis Trx-h2, which harbors two active site cysteine (Cys) residues and an N-terminal extension peptide containing a fatty acid acylation site, remains unclear. In this study, we investigated the physiological function of Trx-h2 by performing several abiotic stress treatments using trx-h1-3 knockout mutant lines, and found that the reductase function of Trx-h2 is critical for cold resistance in Arabidopsis. Plants overexpressing Trx-h2 in the trx-h2 mutant background (Trx-h2OE/trx-h2) showed strong cold tolerant phenotypes compared with Col-0 (wild type) and trx-h2 mutant plants. By contrast, Trx-h2(C/S)OE/trx-h2 plants expressing a variant Trx-h2 protein, in which both active site Cys residues were substituted by serine (Ser) residues, showed high cold sensitivity, similar to trx-h2 plants. Moreover, cold-responsive (COR) genes were highly up-regulated in Trx-h2OE/trx-h2 plants but not in trx-h2 and Trx-h2(C/S)OE/trx-h2 plants under cold conditions. These results explicitly suggest that the cytosolic Trx-h2 protein relays the external cold stress signal to downstream cold defense signaling cascades through its protein disulfide reductase function.
Collapse
Affiliation(s)
- Joung Hun Park
- Division of Applied Life Science (BK21(+)) and PMBBRC, Gyeongsang National University, Jinju, 52828, South Korea
| | - Eun Seon Lee
- Division of Applied Life Science (BK21(+)) and PMBBRC, Gyeongsang National University, Jinju, 52828, South Korea
| | - Ho Byoung Chae
- Division of Applied Life Science (BK21(+)) and PMBBRC, Gyeongsang National University, Jinju, 52828, South Korea
| | - Seol Ki Paeng
- Division of Applied Life Science (BK21(+)) and PMBBRC, Gyeongsang National University, Jinju, 52828, South Korea
| | - Seong Dong Wi
- Division of Applied Life Science (BK21(+)) and PMBBRC, Gyeongsang National University, Jinju, 52828, South Korea
| | - Su Bin Bae
- Division of Applied Life Science (BK21(+)) and PMBBRC, Gyeongsang National University, Jinju, 52828, South Korea
| | - Kieu Anh Thi Phan
- Division of Applied Life Science (BK21(+)) and PMBBRC, Gyeongsang National University, Jinju, 52828, South Korea
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21(+)) and PMBBRC, Gyeongsang National University, Jinju, 52828, South Korea.
| |
Collapse
|
13
|
Kang CH, Park JH, Lee ES, Paeng SK, Chae HB, Hong JC, Lee SY. Redox-Dependent Structural Modification of Nucleoredoxin Triggers Defense Responses against Alternaria brassicicola in Arabidopsis. Int J Mol Sci 2020; 21:ijms21239196. [PMID: 33276577 PMCID: PMC7730559 DOI: 10.3390/ijms21239196] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Revised: 11/21/2020] [Accepted: 12/01/2020] [Indexed: 11/25/2022] Open
Abstract
In plants, thioredoxin (TRX) family proteins participate in various biological processes by regulating the oxidative stress response. However, their role in phytohormone signaling remains largely unknown. In this study, we investigated the functions of TRX proteins in Arabidopsis thaliana. Quantitative polymerase chain reaction (qPCR) experiments revealed that the expression of ARABIDOPSIS NUCLEOREDOXIN 1 (AtNRX1) is specifically induced by the application of jasmonic acid (JA) and upon inoculation with a necrotrophic fungal pathogen, Alternaria brassicicola. The AtNRX1 protein usually exists as a low molecular weight (LMW) monomer and functions as a reductase, but under oxidative stress AtNRX1 transforms into polymeric forms. However, the AtNRX1M3 mutant protein, harboring four cysteine-to-serine substitutions in the TRX domain, did not show structural modification under oxidative stress. The Arabidopsisatnrx1 null mutant showed greater resistance to A. brassicicola than wild-type plants. In addition, plants overexpressing both AtNRX1 and AtNRX1M3 were susceptible to A. brassicicola infection. Together, these findings suggest that AtNRX1 normally suppresses the expression of defense-responsive genes, as if it were a safety pin, but functions as a molecular sensor through its redox-dependent structural modification to induce disease resistance in plants.
Collapse
|
14
|
Yamauchi T, Sasaki S, Lee ES, Tamura T, Seki M, Miwa T, Kobayashi K, Saruta Y, Kitami Y, Sueki H, Watanabe H. Dupilumab treatment ameliorates clinical and hematological symptoms, including blood eosinophilia, in patients with atopic dermatitis. Int J Dermatol 2020; 60:190-195. [PMID: 32989751 DOI: 10.1111/ijd.15183] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/27/2020] [Revised: 08/04/2020] [Accepted: 08/26/2020] [Indexed: 12/22/2022]
Abstract
BACKGROUND Atopic dermatitis (AD) is an allergic disease that affects individuals of various ages. Recently, the IL-4/13 inhibitor dupilumab has gained regulatory approval for clinical use in AD patients. Dupilumab has been reported to reduce several markers of AD, including the serum levels of thymus and activation-regulated chemokine (TARC/CCL17), blood lactate dehydrogenase (LDH), and serum total immunoglobulin E (IgE). METHODS We retrospectively reviewed data from 40 AD patients who were treated with dupilumab. Eczema Area and Severity Index (EASI), Investigator's Global Assessment (IGA), body surface area (BSA) scores, TARC, LDH, total IgE, and eosinophil count in peripheral blood were assessed for a total of 32 weeks. RESULTS The EASI, IGA, and BSA scores improved significantly with treatment, indicating a reduction in AD severity. Serum TARC and LDH levels also significantly decreased with treatment. Serum IgE levels were unchanged at 2 weeks of treatment but decreased significantly between 4 and 32 weeks. The number of eosinophils in the peripheral blood decreased at 4, 16, and 32 weeks after treatment initiation. CONCLUSIONS Several studies have reported that serum TARC, LDH, and total IgE levels are reduced by dupilumab treatment. Our real-world data are the first to demonstrate a reduction in blood eosinophilia in patients who receive clinical treatment with dupilumab.
Collapse
Affiliation(s)
- Teruo Yamauchi
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Shun Sasaki
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Eun Seon Lee
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Takayuki Tamura
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Marina Seki
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Tasuku Miwa
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Kae Kobayashi
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Yusuke Saruta
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Yuki Kitami
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Hirohiko Sueki
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| | - Hideaki Watanabe
- Department of Dermatology, Showa University School of Medicine, Tokyo, Japan
| |
Collapse
|
15
|
Ji MG, Park HJ, Cha JY, Kim JA, Shin GI, Jeong SY, Lee ES, Yun DJ, Lee SY, Kim WY. Expression of Arabidopsis thaliana Thioredoxin-h2 in Brassica napus enhances antioxidant defenses and improves salt tolerance. Plant Physiol Biochem 2020; 147:313-321. [PMID: 31901883 DOI: 10.1016/j.plaphy.2019.12.032] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Revised: 12/25/2019] [Accepted: 12/26/2019] [Indexed: 05/16/2023]
Abstract
Salt stress limits crop productivity worldwide, particularly in arid and heavily irrigated regions. Salt stress causes oxidative stress, in which plant cells accumulate harmful levels of reactive oxygen species (ROS). Thioredoxins (Trxs; EC 1.8.4.8) are antioxidant proteins encoded by a ubiquitous multigene family. Arabidopsis thaliana Trx h-type proteins localize in the cytoplasm and other subcellular organelles, and function in plant responses to abiotic stresses and pathogen attack. Here, we isolated the Arabidopsis genes encoding two cytosolic h-type Trx proteins, AtTrx-h2 and AtTrx-h3 and generated transgenic oilseed rape (Brassica napus) plants overexpressing AtTrx-h2 or AtTrx-h3. Heterologous expression of AtTrx-h2 in B. napus conferred salt tolerance with plants grown on 50 mM NaCl having higher fresh weight and chlorophyll contents compared with controls in hydroponic growth system. By contrast, expression of AtTrx-h3 or the empty vector control did not improve salt tolerance. In addition, AtTrx-h2-overexpressing transgenic plants exhibited lower levels of hydrogen peroxide and higher activities of antioxidant enzymes including peroxidase, catalase, and superoxide dismutase, compared with the plants expressing the empty vector control or AtTrx-h3. These results suggest that AtTrx-h2 is a promising candidate for engineering or breeding crops with enhanced salt stress tolerance.
Collapse
Affiliation(s)
- Myung Geun Ji
- Division of Applied Life Science (BK21 Plus), Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Hee Jin Park
- Institute of Glocal Disease Control, Konkuk University, Seoul, 05029, Republic of Korea; Department of Biomedical Science and Engineering, Konkuk University, Seoul, 05029, Republic of Korea
| | - Joon-Yung Cha
- Division of Applied Life Science (BK21 Plus), Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Jin A Kim
- Department of Agricultural Biotechnology, National Institute of Agricultural Sciences, Rural Development Administration, Jeonju, 54874, Republic of Korea
| | - Gyeong-Im Shin
- Division of Applied Life Science (BK21 Plus), Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Song Yi Jeong
- Division of Applied Life Science (BK21 Plus), Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Eun Seon Lee
- PMBBRC, IALS & RILS, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Dae-Jin Yun
- Department of Biomedical Science and Engineering, Konkuk University, Seoul, 05029, Republic of Korea
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21 Plus), Gyeongsang National University, Jinju, 52828, Republic of Korea; PMBBRC, IALS & RILS, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Woe-Yeon Kim
- Division of Applied Life Science (BK21 Plus), Gyeongsang National University, Jinju, 52828, Republic of Korea; PMBBRC, IALS & RILS, Gyeongsang National University, Jinju, 52828, Republic of Korea.
| |
Collapse
|
16
|
Ko A, Park HJ, Lee ES, Park SB, Kim YK, Choi SY, Ahn S. Comparison of the diagnostic performance of the 2017 and 2018 versions of LI-RADS for hepatocellular carcinoma on gadoxetic acid enhanced MRI. Clin Radiol 2019; 75:319.e1-319.e9. [PMID: 31858990 DOI: 10.1016/j.crad.2019.11.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2019] [Accepted: 11/13/2019] [Indexed: 12/18/2022]
Abstract
AIM To compare the diagnostic performance of the 2017 (v2017) and 2018 versions (v2018) of the Liver Imaging-Reporting and Data System (LI-RADS) for hepatocellular carcinoma (HCC) using gadoxetic acid-enhanced magnetic resonance imaging (Gd-EOB-MRI) and to evaluate the effect in v2018. MATERIALS AND METHODS Treatment-naive patients at high-risk for HCC who underwent Gd-EOB-MRI were included. The LI-RADS categories were assigned according to v2017 and v2018. The diagnostic performances were compared between v2017 and v2018 according to the size and combination of imaging features. RESULTS A total of 117 patients with 137 observations were identified, including 89 HCCs; 76.2% (64/84) of observations with threshold growth were re-classified as subthreshold growth when using v2018 instead of v2017. The final categories changed in nine (14%) cases. For the combination of LR-5/LR-5V, there were no significant differences in sensitivity and specificity between the two versions (sensitivity, 64% versus 58.4%; specificity, 87.5% versus 85.4%; all p>0.05). For the combination of LR-4 and LR-5/5V, the diagnostic performance of v2018 was inferior to that of v2017 when considering only major features (accuracy, 86.1% versus 80.3%, respectively; p=0.013), particularly in observations measuring 10-20 mm, but was comparable after adding the ancillary features (accuracy, 86.9% versus 86.1%, respectively; p=1.00). CONCLUSION In LI-RADS v2018, although a considerable number of observations re-classified subthreshold growth, changes in the assigned categories were insignificant; overall diagnostic performance was comparable to that of v2017, but v2018 might emphasise the value of ancillary features in combination with major features for determining the probability of HCC.
Collapse
Affiliation(s)
- A Ko
- Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, 06973, Republic of Korea
| | - H J Park
- Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, 06973, Republic of Korea.
| | - E S Lee
- Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, 06973, Republic of Korea
| | - S B Park
- Department of Radiology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, 102 Heukseok-ro, Dongjak-gu, Seoul, 06973, Republic of Korea
| | - Y K Kim
- Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
| | - S-Y Choi
- Department of Radiology, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea
| | - S Ahn
- Department of Mathematics, Ajou University, Suwon, Republic of Korea
| |
Collapse
|
17
|
Roh YH, Lee ES, Ahn J, Kim HS, Gong HS, Baek KH, Chung HY. Factors affecting willingness to get assessed and treated for osteoporosis. Osteoporos Int 2019; 30:1395-1401. [PMID: 30944954 DOI: 10.1007/s00198-019-04952-5] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/04/2018] [Accepted: 03/14/2019] [Indexed: 01/06/2023]
Abstract
UNLABELLED Individuals with poor knowledge of osteoporosis and lower socioeconomic status, including being single and having a lower level of annual income, are less likely to be assessed or treated for osteoporosis. Individuals with particular osteoporosis risk factors such as smokers and heavy drinkers are overlooked for diagnosis. Further study is needed to identify and address the existing barriers and to promote osteoporosis management for women with these risk factors. INTRODUCTION Despite the negative health consequences of osteoporosis and the availability of effective treatment, a pervasive and persistent prevention care gap for osteoporosis remains present throughout the world. We attempted to identify the factors affecting the willingness of patients to either undergo or avoid assessment and treatment for osteoporosis. METHODS A nationwide online survey was conducted in 926 Korean women over age 50. The survey included questions addressing three domains: (1) clinical and socio-demographic characteristics, (2) questions concerning the reasons for undergoing or avoiding osteoporosis assessment or treatment, and (3) knowledge of osteoporosis as measured using the modified Korean version of Facts on Osteoporosis Quiz. The assessed and non-assessed participants were compared in terms of their clinical and socioeconomic statuses, reasons for undergoing or avoiding osteoporosis management, and levels of knowledge of osteoporosis. RESULTS The highest-ranked reason for undergoing osteoporosis assessment was fear of osteoporotic fracture, while the highest-ranked reason for avoiding osteoporosis assessment was not feeling a need to get tested for osteoporosis. Participants who sought assessment for osteoporosis were older and more likely to be married, and had greater knowledge of osteoporosis than those who did not seek assessment. The two groups were found to be similar in terms of tobacco use and daily alcohol use. Patients who had been diagnosed with osteoporosis but either did not initiate or discontinued osteoporosis treatment within 1 year were younger and had lower levels of annual income than those who began and continued treatment. CONCLUSION Individuals with poor knowledge of osteoporosis and those of lower socioeconomic status, including those who were single and had a lower level of annual income, were less likely to be assessed and treated for osteoporosis. Individuals with particular osteoporosis risk factors such as smokers and heavy drinkers are overlooked for diagnosis. Further study is needed to identify and address the existing barriers and to promote osteoporosis management for women with these risk factors.
Collapse
Affiliation(s)
- Y H Roh
- Department of Orthopaedic Surgery, Ewha Womans University Medical Center, College of Medicine, Ewha Womans University, Seoul, South Korea
| | - E S Lee
- Department of Obstetrics and Gynecology, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University, Seoul, South Korea
| | - J Ahn
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea Medical Institute, Seoul, South Korea
| | - H S Kim
- Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, College of Medicine, Soonchunhyang University, Seoul, South Korea
| | - H S Gong
- Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, College of Medicine, Seoul National University, Seoul, South Korea
| | - K H Baek
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
| | - H Y Chung
- Division of Endocrinology and Metabolism, Department of Medicine, Kyung Hee University Hospital at Gangdong, School of Medicine, Kyung Hee University, Seoul, South Korea.
| |
Collapse
|
18
|
Jung SY, Jung KW, Won YJ, Kwon Y, Ha J, Kim YA, Kong SY, Lee ES. Abstract P1-08-24: Conditional survival of breast cancer patients: Korean nationwide registry. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p1-08-24] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: Conditional relative survival (CRS) could provide more relevant information on the current prognosis of cancer survivors than standard 5-year relative survival (RS). This study aimed to estimate the 5-year CRS of Korean breast cancer patients.
Patients and Methods: We identified 145,083 breast cancer cases with diagnosis between 2002 and 2013 in the Korea Central Cancer Registry. The CRS was estimated for every year after diagnosis, according to sex, age, histologic types, stage, and year of diagnosis.
Results: The 5-year RS at diagnosis was 90.8% and 10-year RS was 85.7%. Five-year CRS was 91.0% and 94.3% at 1-year and 5-year after diagnosis. Women had better 5-year CRS than men after 5 years of survival (94.3% vs. 79.5%), and very young and very old patients had worse 5-year CRS after 5 years of survival than other age groups (92.2% in <40yr, 92.6% in ≥70yr vs. 95.4% in 40-49, 94.3% in 50-59, and 93.7% in 60-69, relatively). In histologic types, CRS of metaplastic carcinoma has improved from 82.0% to 95.2%, compared to CRS of lobular carcinoma (from 93.1% to 92.5%). Hardly any excess mortality (5-year CRS ≥ 95%) was seen since 7 years after diagnosis. There was hardly any excess mortality at 5 years of survival, for the patients with 40-49 years (95.4%), with localized disease (97.8%), and with metaplastic carcinoma (95.2%).
Conclusion: This study showed that CRS of breast cancer survivors in Korea has been improved, which varied by sex, age, stage, and histologic types. These CRS analysis could provide a more detailed information for survival to breast cancer survivors and clinicians.
Citation Format: Jung S-Y, Jung K-W, Won Y-J, Kwon Y, Ha J, Kim YA, Kong S-Y, Lee ES. Conditional survival of breast cancer patients: Korean nationwide registry [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P1-08-24.
Collapse
Affiliation(s)
- S-Y Jung
- National Cancer Center, Goyang, Republic of Korea
| | - K-W Jung
- National Cancer Center, Goyang, Republic of Korea
| | - Y-J Won
- National Cancer Center, Goyang, Republic of Korea
| | - Y Kwon
- National Cancer Center, Goyang, Republic of Korea
| | - J Ha
- National Cancer Center, Goyang, Republic of Korea
| | - YA Kim
- National Cancer Center, Goyang, Republic of Korea
| | - S-Y Kong
- National Cancer Center, Goyang, Republic of Korea
| | - ES Lee
- National Cancer Center, Goyang, Republic of Korea
| |
Collapse
|
19
|
Kim HJ, Noh WC, Nam SJ, Park BW, Lee ES, Im SA, Jung YS, Yoon JH, Kang SS, Park KH, Lee SJ, Jung J, Lee MH, Cho SH, Kim SY, Kim HA, Han SH, Han W, Hur MH, Ahn SH. Abstract P4-14-04: Time course changes in serum FSH, estradiol, and menstruation restoration in premenopausal patients with breast cancer taking adjuvant tamoxifen after completing chemotherapy: A report from the ASTRRA study. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p4-14-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND
Assessment of restoration of ovarian function after chemotherapy is critical with respect to the initiation of different types of endocrine treatment in young high risk breast cancer patients
METHODS
In total, 1289 women who remained premenopausal or resumed premenopausal status after chemotherapy were randomized to receive 5 years of tamoxifen or 5 years of tamoxifen plus 2 years of ovarian suppression. The patients who did not resume menstruation were followed up for 2 years with tamoxifen treatment after finishing chemotherapy. Prospectively collected consecutive post-chemotherapy hormone and menstruation data were available for 705 breast cancer patients who enrolled tamoxifen-only treatment group or did not resume menstruation during follow up. This analysis evaluated the proportion of patients with pre-menopausal FSH levels (<30 mIU/ml), E2 levels (340 pg/ml), and menstruation at any time point during treatment with tamoxifen.
RESULTS
During 5 years of tamoxifen treatment after chemotherapy for premenopausal breast cancer patients, 62% of patients resumed menstruation. Menstruation returned in 92% of patients under 35 years old but only in 31% of patients over 45 years old. Ovarian function, defined by serum FSH and E2 levels, resumed in 94% and 65% of patients, respectively, over 5 years. Most patients achieved ovarian function restoration during the first 2 years after chemotherapy, with 47.1% resuming menstruation and 86.2% and 50.3% achieving pre-menopausal FSH and E2 levels, respectively, in the first 2 years. Clinical factors related to menstruation restoration were younger age (HR = 6.38, 95% CI 1.33-3.47), 6 month hormone profile after chemotherapy (FSH<30: HR=1.67, 95% CI 1.28-2.17; E2 >40: HR=2.96, 95% CI 2.25-3.89), and anthracycline without taxane chemotherapy (HR=1.63, 95% CI 1.25-2.13).
CONCLUSIONS
During 5 years of tamoxifen treatment after chemotherapy, half of patients experienced menstruation restoration, including most very young patients under 35 years. The majority of patients experienced menstruation restoration in the first 2 years of tamoxifen treatment.
Citation Format: Kim HJ, Noh WC, Nam SJ, Park B-w, Lee ES, Im SA, Jung YS, Yoon JH, Kang SS, Park KH, Lee S-J, Jung J, Lee MH, Cho SH, Kim SY, Kim H-A, Han S-H, Han W, Hur MH, Ahn SH. Time course changes in serum FSH, estradiol, and menstruation restoration in premenopausal patients with breast cancer taking adjuvant tamoxifen after completing chemotherapy: A report from the ASTRRA study [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P4-14-04.
Collapse
Affiliation(s)
- HJ Kim
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - WC Noh
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - SJ Nam
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - B-w Park
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - ES Lee
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - SA Im
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - YS Jung
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - JH Yoon
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - SS Kang
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - KH Park
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - S-J Lee
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - J Jung
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - MH Lee
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - SH Cho
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - SY Kim
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - H-A Kim
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - S-H Han
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - W Han
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - MH Hur
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| | - SH Ahn
- College of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea; Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; Yonsei University College of Medicine, Seoul, Korea; Center for Breast Cancer, National Cancer Center, Goyang, Korea; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea; Ajou University, School of Medicine, Suwon, Korea; Chonnam National University Hwasun Hospital, Gwangju, Korea; Cheil General Hospital and Women's Healthcare Center, Dankook University College of Medicine, Seoul, Korea; Korea University Anam Hospital, Seoul, Korea; Yeungnam University Hospital, Daegu, Korea; Gangnam Severance Hospital, Seoul, Korea; SoonChunHyang University Colleage of Medicine, Seoul, Korea; Dong-A University Hospital, Busan, Korea; Soonchunhyang University College of Medicine, Cheonan Hospital, Cheon
| |
Collapse
|
20
|
Jung SY, Han JH, Park SJ, Lee EG, Lee MH, Lee ES, Kang HS, Lee KS, Park IH, Sim SH, Jeong HJ, Kwon Y, Lee DE, Joo J, Kim SK, Lee S. Abstract P3-03-05: Not presented. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-p3-03-05] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was not presented at the conference.
Citation Format: Jung S-Y, Han JH, Park SJ, Lee E-G, Lee MH, Lee ES, Kang H-S, Lee KS, Park IH, Sim SH, Jeong HJ, Kwon Y, Lee D-E, Joo J, Kim S-K, Lee S. Not presented [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr P3-03-05.
Collapse
Affiliation(s)
- S-Y Jung
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - JH Han
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - SJ Park
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - E-G Lee
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - MH Lee
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - ES Lee
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - H-S Kang
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - KS Lee
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - IH Park
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - SH Sim
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - HJ Jeong
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - Y Kwon
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - D-E Lee
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - J Joo
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - S-K Kim
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| | - S Lee
- National Cancer Center, Goyang, Republic of Korea; Wonkwang University Sanbon Hospital, Gunpo, Republic of Korea; Keimyung University School of Medicine, Daegu, Republic of Korea
| |
Collapse
|
21
|
Chi YH, Koo SS, Oh HT, Lee ES, Park JH, Phan KAT, Wi SD, Bae SB, Paeng SK, Chae HB, Kang CH, Kim MG, Kim WY, Yun DJ, Lee SY. The Physiological Functions of Universal Stress Proteins and Their Molecular Mechanism to Protect Plants From Environmental Stresses. Front Plant Sci 2019; 10:750. [PMID: 31231414 PMCID: PMC6560075 DOI: 10.3389/fpls.2019.00750] [Citation(s) in RCA: 55] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/19/2018] [Accepted: 05/22/2019] [Indexed: 05/13/2023]
Abstract
Since the original discovery of a Universal Stress Protein (USP) in Escherichia coli, a number of USPs have been identified from diverse sources including archaea, bacteria, plants, and metazoans. As their name implies, these proteins participate in a broad range of cellular responses to biotic and abiotic stresses. Their physiological functions are associated with ion scavenging, hypoxia responses, cellular mobility, and regulation of cell growth and development. Consistent with their roles in resistance to multiple stresses, USPs show a wide range of structural diversity that results from the diverse range of other functional motifs fused with the USP domain. As well as providing structural diversity, these catalytic motifs are responsible for the diverse biochemical properties of USPs and enable them to act in a number of cellular signaling transducers and metabolic regulators. Despite the importance of USP function in many organisms, the molecular mechanisms by which USPs protect cells and provide stress resistance remain largely unknown. This review addresses the diverse roles of USPs in plants and how the proteins enable plants to resist against multiple stresses in ever-changing environment. Bioinformatic tools used for the collection of a set of USPs from various plant species provide more than 2,100 USPs and their functional diversity in plant physiology. Data from previous studies are used to understand how the biochemical activity of plant USPs modulates biotic and abiotic stress signaling. As USPs interact with the redox protein, thioredoxin, in Arabidopsis and reactive oxygen species (ROS) regulates the activity of USPs, the involvement of USPs in redox-mediated defense signaling is also considered. Finally, this review discusses the biotechnological application of USPs in an agricultural context by considering the development of novel stress-resistant crops through manipulating the expression of USP genes.
Collapse
Affiliation(s)
- Yong Hun Chi
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Sung Sun Koo
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Hun Taek Oh
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Eun Seon Lee
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Joung Hun Park
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Kieu Anh Thi Phan
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Seong Dong Wi
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Su Bin Bae
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Seol Ki Paeng
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Ho Byoung Chae
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Chang Ho Kang
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
| | - Min Gab Kim
- College of Pharmacy and Research Institute of Pharmaceutical Science, Gyeongsang National University, Jinju, South Korea
| | - Woe-Yeon Kim
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
- Institute of Agricultural and Life Science (IALS), Gyeongsang National University, Jinju, South Korea
| | - Dae-Jin Yun
- Department of Biomedical Science and Engineering, Konkuk University, Seoul, South Korea
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21Plus), Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, South Korea
- *Correspondence: Sang Yeol Lee,
| |
Collapse
|
22
|
Park JH, Kang CH, Nawkar GM, Lee ES, Paeng SK, Chae HB, Chi YH, Kim WY, Yun DJ, Lee SY. EMR, a cytosolic-abundant ring finger E3 ligase, mediates ER-associated protein degradation in Arabidopsis. New Phytol 2018; 220:163-177. [PMID: 29932218 DOI: 10.1111/nph.15279] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/21/2017] [Accepted: 05/18/2018] [Indexed: 05/16/2023]
Abstract
Investigation of the endoplasmic reticulum-associated degradation (ERAD) system in plants led to the identification of ERAD-mediating RING finger protein (EMR) as a plant-specific ERAD E3 ligase from Arabidopsis. EMR was significantly up-regulated under endoplasmic reticulum (ER) stress conditions. The EMR protein purified from bacteria displayed high E3 ligase activity, and tobacco leaf-produced EMR mediated mildew resistance locus O-12 (MLO12) degradation in a proteasome-dependent manner. Subcellular localization and coimmunoprecipitation analyses showed that EMR forms a complex with ubiquitin-conjugating enzyme 32 (UBC32) as a cytosolic interaction partner. Mutation of EMR and RNA interference (RNAi) increased the tolerance of plants to ER stress. EMR RNAi in the bri1-5 background led to partial recovery of the brassinosteroid (BR)-insensitive phenotypes as compared with the original mutant plants and increased ER stress tolerance. The presented results suggest that EMR is involved in the plant ERAD system that affects BR signaling under ER stress conditions as a novel Arabidopsis ring finger E3 ligase mainly present in cytosol while the previously identified ERAD E3 components are typically membrane-bound proteins.
Collapse
Affiliation(s)
- Joung Hun Park
- Division of Applied Life Sciences (BK21+) and Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea
| | - Chang Ho Kang
- Division of Applied Life Sciences (BK21+) and Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea
| | - Ganesh M Nawkar
- Division of Applied Life Sciences (BK21+) and Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea
| | - Eun Seon Lee
- Division of Applied Life Sciences (BK21+) and Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea
| | - Seol Ki Paeng
- Division of Applied Life Sciences (BK21+) and Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea
| | - Ho Byoung Chae
- Division of Applied Life Sciences (BK21+) and Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea
| | - Yong Hun Chi
- Division of Applied Life Sciences (BK21+) and Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea
| | - Woe Yeon Kim
- Division of Applied Life Sciences (BK21+) and Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea
| | - Dae-Jin Yun
- Department of Biomedical Science and Engineering, Konkuk University, Seoul, 05029, Korea
| | - Sang Yeol Lee
- Division of Applied Life Sciences (BK21+) and Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Jinju, 52828, Korea
| |
Collapse
|
23
|
Shin EJ, Seo JK, Lee EJ, Lee ES, Shin MK. Diagnostic utility of skin autofluorescence when patch test results are doubtful. Skin Res Technol 2018; 25:96-99. [PMID: 30055047 DOI: 10.1111/srt.12615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/23/2018] [Indexed: 11/29/2022]
Abstract
BACKGROUND The standard diagnostic test for allergic contact dermatitis is the patch test, which can also be used to identify irritant contact dermatitis. Doubtful reactions (?+) can be often clinically relevant to individuals and can require additional tests. OBJECTIVES The purpose of this study was to examine whether autofluorescence (AF) measurements in patients with doubtful reactions are helpful in diagnosing contact dermatitis. METHODS Patients with a history of contact dermatitis were patch tested on the upper back for 48-hours of occlusion using aqueous solutions of 5% sodium lauryl sulfate. Reaction intensity was scored, and AF was measured on reactive lesions and non-lesions. Three dermatologists classified the results as positive or negative using the fluorescence photographs of patients with a doubtful reaction. RESULTS Among doubtful reactions, the R/G% values were significantly higher in the AF- based positive group than in the negative group (P = .0086). On the other hand, the heterogeneity values of R, G, and B (HR, HG, HB) were significantly lower in the AF-based positive group (P = .0026, .0046, .0004 respectively). CONCLUSIONS Measuring AF along with the clinical readings can help confirm doubtful patch test reactions.
Collapse
Affiliation(s)
- E-J Shin
- Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea
| | - J-K Seo
- Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea
| | - E J Lee
- Skin Research Center/DERMAPRO Ltd., Seoul, Korea
| | - E S Lee
- Skin Research Center/DERMAPRO Ltd., Seoul, Korea
| | - M K Shin
- Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea
| |
Collapse
|
24
|
Lee ES, Kang CH, Park JH, Lee SY. Physiological Significance of Plant Peroxiredoxins and the Structure-Related and Multifunctional Biochemistry of Peroxiredoxin 1. Antioxid Redox Signal 2018; 28:625-639. [PMID: 29113450 DOI: 10.1089/ars.2017.7400] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
SIGNIFICANCE Sessile plants respond to oxidative stress caused by internal and external stimuli by producing diverse forms of enzymatic and nonenzymatic antioxidant molecules. Peroxiredoxins (Prxs) in plants, including the Prx1, Prx5, Prx6, and PrxQ isoforms, constitute a family of antioxidant enzymes and play important functions in cells. Each Prx localizes to a specific subcellular compartment and has a distinct function in the control of plant growth, development, cellular metabolism, and various aspects of defense signaling. Recent Advances: Prx1, a typical Prx in plant chloroplasts, has redox-dependent multiple functions. It acts as a hydrogen peroxide (H2O2)-catalyzing peroxidase, a molecular chaperone, and a biological circadian marker. Prx1 undergoes a functional switching from a peroxidase to a molecular chaperone in response to oxidative stress, concomitant with the structural changes from a low-molecular-weight species to high-molecular-weight complexes mediated by the post-translational modification of its active site Cys residues. The redox status of the protein oscillates diurnally between hyperoxidation and reduction, showing a circadian rhythmic output. These dynamic structural and functional transformations mediate the effect of plant Prx1 on protecting plants from a myriad of harsh environmental stresses. CRITICAL ISSUES The multifunctional diversity of plant Prxs and their roles in cellular defense signaling depends on their specific interaction partners, which remain largely unidentified. Therefore, the identification of Prx-interacting proteins is necessary to clarify their physiological significance. FUTURE DIRECTIONS Since the functional specificity of the four plant Prx isoforms remains unclear, future studies should focus on investigating the physiological importance of each Prx isotype. Antioxid. Redox Signal. 28, 625-639.
Collapse
Affiliation(s)
- Eun Seon Lee
- Division of Applied Life Science (BK21+ Program) and PMBBRC, Gyeongsang National University , Jinju, Korea
| | - Chang Ho Kang
- Division of Applied Life Science (BK21+ Program) and PMBBRC, Gyeongsang National University , Jinju, Korea
| | - Joung Hun Park
- Division of Applied Life Science (BK21+ Program) and PMBBRC, Gyeongsang National University , Jinju, Korea
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21+ Program) and PMBBRC, Gyeongsang National University , Jinju, Korea
| |
Collapse
|
25
|
Nawkar GM, Lee ES, Shelake RM, Park JH, Ryu SW, Kang CH, Lee SY. Activation of the Transducers of Unfolded Protein Response in Plants. Front Plant Sci 2018; 9:214. [PMID: 29515614 DOI: 10.3389/fpls.2018.00214/full] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 11/08/2017] [Accepted: 02/05/2018] [Indexed: 05/24/2023]
Abstract
Maintenance of homeostasis of the endoplasmic reticulum (ER) ensures the balance between loading of nascent proteins and their secretion. Certain developmental conditions or environmental stressors affect protein folding causing ER stress. The resultant ER stress is mitigated by upregulating a set of stress-responsive genes in the nucleus modulating the mechanism of the unfolded protein response (UPR). In plants, the UPR is mediated by two major pathways; by the proteolytic processing of bZIP17/28 and by the IRE1-mediated splicing of bZIP60 mRNA. Recent studies have shown the involvement of plant-specific NAC transcription factors in UPR regulation. The molecular mechanisms activating plant-UPR transducers are only recently being unveiled. This review focuses on important structural features involved in the activation of the UPR transducers like bZIP17/28/60, IRE1, BAG7, and NAC017/062/089/103. Also, we discuss the activation of the UPR pathways, including BAG7-bZIP28 and IRE1-bZIP60, in detail, together with the NAC-TFs, which adds a new paradigm to the plant UPR.
Collapse
Affiliation(s)
- Ganesh M Nawkar
- Division of Applied Life Sciences (BK21 Plus) and Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University, Jinju, South Korea
| | - Eun Seon Lee
- Division of Applied Life Sciences (BK21 Plus) and Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University, Jinju, South Korea
| | - Rahul M Shelake
- Division of Applied Life Sciences (BK21 Plus) and Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University, Jinju, South Korea
| | - Joung Hun Park
- Division of Applied Life Sciences (BK21 Plus) and Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University, Jinju, South Korea
| | - Seoung Woo Ryu
- Division of Applied Life Sciences (BK21 Plus) and Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University, Jinju, South Korea
| | - Chang Ho Kang
- Division of Applied Life Sciences (BK21 Plus) and Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University, Jinju, South Korea
| | - Sang Yeol Lee
- Division of Applied Life Sciences (BK21 Plus) and Plant Molecular Biology and Biotechnology Research Center (PMBBRC), Gyeongsang National University, Jinju, South Korea
| |
Collapse
|
26
|
Lee EG, Kang H, Park SJ, Han JH, Jung SY, Lee S, Kang HS, Park B, Kong SY, Lim MC, Park SY, Lee ES. Abstract P4-06-12: Different patterns of risk reducing decisions in affected or unaffected BRCA mutation carriers. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p4-06-12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND
Risk-reducing (RR) management decreases the risk of breast cancer and BRCA related gynecologic cancer. However, there are fewer reports on the RR management in Asia compared to Western countries.The aim of this study is to identify risk reducing management patterns with BRCA1 or BRCA2 mutation carriers.
METHODS
The study group consisted of all consecutive 1104 breast cancer, ovarian patients and their families of high-risk patients who underwent BRCA gene testing in National Cancer Center, Korea from 2008 to 2016. A total 220 BRCA mutations (19.9%) were detected with 125(11.3%) of BRCA1 gene and 95 (8.6%) of BRCA2 gene.
RESULTS
Out of 220 BRCA mutations carriers, they were consisted of 83 breast cancers, 10 ovarian cancers, 7 both cancers, and 120 unaffected carriers. Among them, 42 were men and 178 were women. About 90 % (198/ 220) had the familial history of breast, ovarian or both malignancies (113 in BRCA1 and 85 in BRCA2 mutation (p=0.821)).
All 42 men chose surveillance. Among 178 female BRCA mutation carriers, 98(55.1%) underwent risk reducing management including 18(10.1%) of chemoprevention, and 80(49.9%) had risk-reducing surgeries (RRSs) (1 case of risk-reducing mastectomy, 76 of risk reducing bilateral salphingo-oophorectomy (RRSO), and 3 of both) and 80 (54.9%) chose only intensive surveillance for both of breast and ovary cancer.
In affected carriers with breast cancer, 59 (71.1%) underwent RR management (1 case of risk reducing mastectomy, 53 of RRSO, 3 of both surgery, and 2 of chemoprevention). There was no risk reducing management in affected carrier with ovarian cancer patients. In 78 unaffected women carriers, 39(50.0%) women received RR management (23(29.5%) cases of RRSO and 16(20.5%) cases of chemoprevention). The rates of RRSs have increased annually since the 2013 year, (prior to 2013 vs. since 2013, RRSs 28.6% (6 cases/21 carriers) vs. 37.2% (74/199), p<0.01).
CONCLUSION
This study was conducted on the largest numbers of BRCA mutation carriers in Asian countries. RRSO is the more preferred management for affected carriers with breast cancer or unaffected carriers. The results might be explained by the severity of the illness and that RRSO was only reimbursed RR strategy from the Korean Government Insurance. Tailored genetic counseling and insurance policy may enhance overall levels of RR management.
Citation Format: Lee EG, Kang H, Park SJ, Han JH, Jung S-Y, Lee S, Kang H-S, Park B, Kong S-Y, Lim MC, Park S-Y, Lee ES. Different patterns of risk reducing decisions in affected or unaffected BRCA mutation carriers [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P4-06-12.
Collapse
Affiliation(s)
- EG Lee
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - H Kang
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - SJ Park
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - JH Han
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - S-Y Jung
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - S Lee
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - H-S Kang
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - B Park
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - S-Y Kong
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - MC Lim
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - S-Y Park
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - ES Lee
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea; Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Gyeonggi-do, Korea; Center for Uterine Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi-do, Korea
| |
Collapse
|
27
|
You JY, Bae SY, Jung SP, Lee ES. Abstract P3-01-12: Withdrawn. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p3-01-12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Collapse
Affiliation(s)
- JY You
- Korea University Medical Center, Seoul, Republic of Korea; National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea
| | - SY Bae
- Korea University Medical Center, Seoul, Republic of Korea; National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea
| | - SP Jung
- Korea University Medical Center, Seoul, Republic of Korea; National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea
| | - ES Lee
- Korea University Medical Center, Seoul, Republic of Korea; National Cancer Center, Goyang, Gyeonggi-do, Republic of Korea
| |
Collapse
|
28
|
Nawkar GM, Lee ES, Shelake RM, Park JH, Ryu SW, Kang CH, Lee SY. Activation of the Transducers of Unfolded Protein Response in Plants. Front Plant Sci 2018; 9:214. [PMID: 29515614 PMCID: PMC5826264 DOI: 10.3389/fpls.2018.00214] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/08/2017] [Accepted: 02/05/2018] [Indexed: 05/19/2023]
Abstract
Maintenance of homeostasis of the endoplasmic reticulum (ER) ensures the balance between loading of nascent proteins and their secretion. Certain developmental conditions or environmental stressors affect protein folding causing ER stress. The resultant ER stress is mitigated by upregulating a set of stress-responsive genes in the nucleus modulating the mechanism of the unfolded protein response (UPR). In plants, the UPR is mediated by two major pathways; by the proteolytic processing of bZIP17/28 and by the IRE1-mediated splicing of bZIP60 mRNA. Recent studies have shown the involvement of plant-specific NAC transcription factors in UPR regulation. The molecular mechanisms activating plant-UPR transducers are only recently being unveiled. This review focuses on important structural features involved in the activation of the UPR transducers like bZIP17/28/60, IRE1, BAG7, and NAC017/062/089/103. Also, we discuss the activation of the UPR pathways, including BAG7-bZIP28 and IRE1-bZIP60, in detail, together with the NAC-TFs, which adds a new paradigm to the plant UPR.
Collapse
|
29
|
Lee ES, Ohk TG, Lee WW, Park SM, Ahn JY, Sohn YD, Ahn HC. A Death Case of Bulimia Nervosa Presented with Abdominal Distention. HONG KONG J EMERG ME 2017. [DOI: 10.1177/102490791201900409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Bulimia nervosa is one of the eating disorders. Psychological manifestations of this disease, such as guilt or denial, may interfere with patient communication. The patients with bulimia nervosa are most commonly between ages of 17 and 25 years old, and often maintain normal body weight. It is not easy to screen out and diagnose bulimia nervosa patients at the emergency department. We reported two bulimia nervosa patients who visited our emergency department with abdominal distension, and one of them died of abdominal compartment syndrome. We confirmed collapse of the abdominal aorta and key arteries in enhanced abdominal computed tomography. Promptly, we performed gastrostomy for reduction of abdominal pressure, but she finally succumbed due to multiple organ failure 12 hours after the surgery.
Collapse
|
30
|
Lee HG, Agpoon KJ, Besana AN, Lim HK, Jang HS, Lee ES. Re: re: Mandibular stability using sliding compared with conventional four-hole plates for fixation after bilateral sagittal split ramus osteotomy for mandibular setback. Br J Oral Maxillofac Surg 2017; 56:80-81. [PMID: 29183648 DOI: 10.1016/j.bjoms.2017.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2017] [Accepted: 10/04/2017] [Indexed: 11/26/2022]
Affiliation(s)
- H G Lee
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - K J Agpoon
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - A N Besana
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - H K Lim
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - H S Jang
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - E S Lee
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| |
Collapse
|
31
|
Do KY, Lee ES, Lee KS. Association between excessive Internet use and oral health behaviors of Korean adolescents: A 2015 national survey. Community Dent Health 2017; 34:183-189. [PMID: 28872814 DOI: 10.1922/cdh_4107do07] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 12/21/2016] [Accepted: 03/31/2017] [Indexed: 11/11/2022]
Abstract
OBJECTIVE This study aimed to investigate excessive Internet use's (EIU's) association with oral health behaviors among Korean adolescents. BASIC RESEARCH DESIGN This cross-sectional study was based on the 11th Korea Youth Risk Behavior Web-based Survey (2015). PARTICIPANTS 68,043 school students aged 13-18 years (35,204 boys and 32,839 girls). Data on, 45,271 (23,354 males and 21,917 females using the Internet on weekdays) and 49,324 (27,448 males and 21,876 females using the Internet on weekends) were analyzed after excluding questionnaires with missing values. MAIN OUTCOME MEASURES The key variables were oral health behaviors (tooth-brushing frequency and tooth brushing after lunch at school, and preventive oral health behaviors), EIU (hours of Internet use on weekdays and weekends, excluding use for academic purposes). RESULTS Compared to the general groups, the odds ratio (OR) for less tooth-brushing was 4.04 (95%CI=2.990-5.459) and 3.55-fold higher (95% CI=2.703-4.659) in the high-risk groups for weekday and weekend EIU, respectively. For post-lunch tooth-brushing, compared to the general groups, the OR for less tooth-brushing was 1.7-fold higher in the high-risk groups for EIU during weekdays and weekends. The OR for no preventive behavior was significantly higher in the high-risk groups than in the potential-risk and general groups. CONCLUSIONS Policies moderating adolescents' EIU may enable appropriate oral health behaviors.
Collapse
Affiliation(s)
- K Y Do
- Department of Public Health, Graduate School, The Catholic University of Korea
| | - E S Lee
- Department of Dental Hygiene, Hanyang Women's University of Korea
| | - K S Lee
- Department of Preventive Medicine, College of Medicine, The Catholic University of Korea
| |
Collapse
|
32
|
Kim HM, Lee BR, Lee ES, Kwon MH, Huh JH, Kwon BE, Park EK, Chang SY, Kweon MN, Kim PH, Ko HJ, Chung CH. iNKT cells prevent obesity-induced hepatic steatosis in mice in a C-C chemokine receptor 7-dependent manner. Int J Obes (Lond) 2017; 42:270-279. [PMID: 28811651 PMCID: PMC5803573 DOI: 10.1038/ijo.2017.200] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/30/2017] [Revised: 06/19/2017] [Accepted: 07/21/2017] [Indexed: 02/08/2023]
Abstract
Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis are characterized by an increase in hepatic triglyceride content with infiltration of immune cells, which can cause steatohepatitis and hepatic insulin resistance. C-C chemokine receptor 7 (CCR7) is primarily expressed in immune cells, and CCR7 deficiency leads to the development of multi-organ autoimmunity, chronic renal disease and autoimmune diabetes. Here, we investigated the effect of CCR7 on hepatic steatosis in a mouse model and its underlying mechanism. Our results demonstrated that body and liver weights were higher in the CCR7−/− mice than in the wild-type (WT) mice when they were fed a high-fat diet. Further, glucose tolerance and insulin sensitivity were markedly diminished in CCR7−/− mice. The number of invariant natural killer T (iNKT) cells was reduced in the livers of the CCR7−/− mice. Moreover, liver inflammation was detected in obese CCR7−/− mice, which was ameliorated by the adoptive transfer of hepatic mononuclear cells from WT mice, but not through the transfer of hepatic mononuclear cells from CD1d−/− or interleukin-10-deficient (IL-10−/−) mice. Overall, these results suggest that CCR7+ mononuclear cells in the liver could regulate obesity-induced hepatic steatosis via induction of IL-10-expressing iNKT cells.
Collapse
Affiliation(s)
- H M Kim
- Department of Global Medical Science, Yonsei University Wonju College of Medicine, Wonju, Korea.,Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - B R Lee
- Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Chuncheon, Korea
| | - E S Lee
- Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - M H Kwon
- Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - J H Huh
- Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
| | - B-E Kwon
- Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Chuncheon, Korea
| | - E-K Park
- Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Chuncheon, Korea
| | - S-Y Chang
- College of Pharmacy, Ajou University, Suwon, Korea
| | - M-N Kweon
- Mucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul, Korea
| | - P-H Kim
- Department of Molecular Bioscience, School of Biomedical Science, Kangwon National University, Chuncheon, Korea
| | - H-J Ko
- Laboratory of Microbiology and Immunology, College of Pharmacy, Kangwon National University, Chuncheon, Korea
| | - C H Chung
- Department of Global Medical Science, Yonsei University Wonju College of Medicine, Wonju, Korea.,Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
| |
Collapse
|
33
|
Cho JN, Song EJ, Lee MH, Jung SY, Lee S, Kang HS, Sim SH, Park IH, Lee KS, Kim YJ, Kim SK, Kwon Y, Nam BH, Lee ES. Abstract P2-01-12: Development of prediction model for omission of sentinel lymph node biopsy in T1 breast cancer. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p2-01-12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
INTRODUCTION
Axillary sentinel lymph node (SLN) biopsy is a standard method for axillary nodal staging in the treatment of breast cancer. However, along with the trends to SLN performed only without additional axillary lymph node dissection, it's time to be considered omission of SLN for selective patients. We developed a prediction model to assess the negative probability of sentinel lymph node metastasis, specifically focus on the patients with clinical T1 breast cancer.
METHODS and MATERIALS
The study group consisted of 513 consecutive patients with clinical T1 breast cancer, who had undergone primary surgery between 2007 and 2012. The clinicopathologic factors and imaging modalities including breast ultrasound (US), magnetic resonance imaging (MRI), chest computed tomography (CT), and positron emission tomography (PET) were evaluated. Patients who fulfilled our inclusion criteria were randomized into experimental and validation set by 3:1 ratio. In the experimental group (n = 256), multivariate logistic regression analysis was used to analyze the association of each variable with the likelihood of SLN metastases. A prediction model was developed based on the patients in the experimental group and was validated with internal patient cohorts.
RESULTS
Of the 513 patients, 119 (23.1%) were found to have SLN metastases. In univariate analysis, presence of lymphovascular invasion (P < 0.001) and suspicious finding of preoperative image studies (US, PET, and MRI, P < 0.001) were independent positive predictors of SLN metastases. In multivariate analysis of experimental group, estrogen receptor status (P = 0.012), presence of lymphatic invasion (P < 0.001), and suspicious finding of preoperative image studies (US, PET, and MRI, P < 0.001) were each associated with involvement of SLN. A prediction model based on this analysis consists of 9 rows including 6 variables (age, estrogen receptor status, presence of lymphatic invasion, and results of preoperative US, PET or CT, MRI). The sum of assigned points for all six variables made corresponding value of negative probability of SLN metastasis. The accuracy of prediction model applied to the validation group, as measured by the area under the receiver operating curve was 0.789.
CONCLUSIONS
The prediction model developed here may be a useful tool to assess SLN involvement for clinical T1 breast cancer patients. And prospective study for additional validation of the prediction model is currently in preparation, exploring the possibility of SLN biopsy omission.
Citation Format: Cho JN, Song EJ, Lee MH, Jung S-Y, Lee S, Kang H-S, Sim SH, Park IH, Lee KS, Kim YJ, Kim S-K, Kwon Y, Nam B-H, Lee ES. Development of prediction model for omission of sentinel lymph node biopsy in T1 breast cancer [abstract]. In: Proceedings of the 2016 San Antonio Breast Cancer Symposium; 2016 Dec 6-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2017;77(4 Suppl):Abstract nr P2-01-12.
Collapse
Affiliation(s)
- JN Cho
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - EJ Song
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - MH Lee
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - S-Y Jung
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - S Lee
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - H-S Kang
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - SH Sim
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - IH Park
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - KS Lee
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - YJ Kim
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - S-K Kim
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - Y Kwon
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - B-H Nam
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| | - ES Lee
- Center for Breast Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Gyeongsang National University Hospital, Jinu, Korea
| |
Collapse
|
34
|
Chi YH, Melencion SMB, Alinapon CV, Kim MJ, Lee ES, Paeng SK, Park JH, Nawkar GM, Jung YJ, Chae HB, Kang CH, Lee SY. The membrane-tethered NAC transcription factor, AtNTL7, contributes to ER-stress resistance in Arabidopsis. Biochem Biophys Res Commun 2017; 488:641-647. [PMID: 28088515 DOI: 10.1016/j.bbrc.2017.01.047] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2017] [Accepted: 01/10/2017] [Indexed: 12/12/2022]
Abstract
We screened for endoplasmic reticulum (ER) stress-resistant mutants among 25 mutants of the Arabidopsis NTL (NAC with Transmembrane motif 1-Like) family. We identified a novel mutant, SALK_044777, showing strong resistance to ER stress. RT-PCR and genomic DNA sequence analyses identified the mutant as atntl7, which harbors a T-DNA insertion in the fourth exon of AtNTL7. Two other atntl7-mutant alleles, in which T-DNA was inserted in the second exon and third intron of AtNTL7, respectively, showed ER-stress sensitive phenotypes, suggesting that SALK_044777 is a gain-of-function mutant. Arabidopsis plants overexpressing AtNTL7 showed strong ER-stress resistance. Our findings suggest that AtNTL7 fragment is cleaved from the ER membrane under ER stress and translocates into the nucleus to induce downstream ER-stress responsive genes.
Collapse
Affiliation(s)
- Yong Hun Chi
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Sarah Mae Boyles Melencion
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Cresilda Vergara Alinapon
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Min Ji Kim
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Eun Seon Lee
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Seol Ki Paeng
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Joung Hun Park
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Ganesh M Nawkar
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Young Jun Jung
- National Institute of Ecology, 1210 Geumgang-ro, Maseo-myeon, Seocheon-gun 33657, Republic of Korea
| | - Ho Byoung Chae
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Chang Ho Kang
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea
| | - Sang Yeol Lee
- Division of Applied Life Science (BK21(+) Program) and PMBBRC, Gyeongsang National University, Jinju, 52828, Republic of Korea.
| |
Collapse
|
35
|
Youn SW, Kim BR, Cho S, Seo SJ, Lee ES, Roh JY, Choi GS, Lee MG. Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study. J Eur Acad Dermatol Venereol 2017; 31:e298-e299. [PMID: 27976465 DOI: 10.1111/jdv.14083] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- S W Youn
- Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
| | - B R Kim
- Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
| | - S Cho
- Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.,SMG-SNU Boramae Medical Center, Seoul, Korea
| | - S J Seo
- Department of Dermatology, Chung-Ang University Hospital, Seoul, Korea
| | - E S Lee
- Department of Dermatology, Ajou University Medical Center, Suwon, Korea
| | - J Y Roh
- Department of Dermatology, Gachon University Gil Hospital, Incheon, Korea
| | - G S Choi
- Department of Dermatology, Inha University Hospital, Incheon, Korea
| | - M G Lee
- Department of Dermatology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
| | | |
Collapse
|
36
|
Lee HG, Agpoon KJ, Besana AN, Lim HK, Jang HS, Lee ES. Mandibular stability using sliding or conventional four-hole plates for fixation after bilateral sagittal split ramus osteotomy for mandibular setback. Br J Oral Maxillofac Surg 2016; 55:378-382. [PMID: 27931722 DOI: 10.1016/j.bjoms.2016.11.318] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2016] [Accepted: 11/18/2016] [Indexed: 11/16/2022]
Abstract
Our aim was to compare the postoperative stability of the mandible when two different fixation methods had been used after bilateral sagittal split ramus osteotomy (BSSRO) for mandibular setback. The study included 23 patients who had two-jaw BSSRO mandibular setback at the Department of Oromaxillofacial Surgery, Korea University Guro Hospital, between January 2011 and June 2014. The first group (four-hole (control) group, n=13) comprised patients whose bony segments were fixed with conventional four-hole plates, and the second (sliding plate (experimental) group, n=10) included patients whose bone segments were fixed with sliding plates. Lateral cephalograms were taken and analysed at three time points: preoperatively (T1), and one week (T2), and 1year (T3) postoperatively. The Mann-Whitney U test was used to compare the postoperative stability of the mandible in each group. There were no significant differences between the two groups in changes in the horizontal and vertical positions of point B and pogonion postoperatively, nor were there any significant differences between them in ramal inclination and inclination of the SN plane with point B at the given time points (p=>0.05 in surgical changes in the mandible immediately after surgery and 0.397, 0.616, 0.082, 0.951, 0.901, 0.476 in postoperative changes in the mandible 1 week to 1 year after surgery). Like the conventional four-hole plate, the sliding plate can also be used to achieve stability in the fixation of mandibular bone segments after BSSRO.
Collapse
Affiliation(s)
- H G Lee
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - K J Agpoon
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - A N Besana
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - H K Lim
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - H S Jang
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| | - E S Lee
- Department of Oral and Maxillofacial Surgery, Korea University Graduate School of Clinical Dentistry, Seoul, Republic of Korea.
| |
Collapse
|
37
|
Oh B, Choi WS, Park SB, Cho B, Yang YJ, Lee ES, Lee JH. Efficacy and safety of ursodeoxycholic acid composite on fatigued patients with elevated liver function and/or fatty liver: a multi-centre, randomised, double-blinded, placebo-controlled trial. Int J Clin Pract 2016; 70:302-11. [PMID: 26997458 PMCID: PMC5071730 DOI: 10.1111/ijcp.12790] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/15/2023] Open
Abstract
AIM The aim of this study was to assess the effects of ursodeoxycholic acid composite (URSA-S) on fatigue in patients with elevated liver function tests and/or fatty liver disease. METHODS In this multi-centre randomised double-blinded placebo-controlled trial, 168 adults who were diagnosed with fatigue based on our criteria and had elevated liver function tests (but not > 5 times the normal level) and/or fatty liver on ultrasonography, were randomised to either the placebo or URSA-S administration group. The rate of improvement of checklist individual strength (CIS) using a cut-off of 76 points at the end of the study (8 weeks), the change in fatigue scale [CIS score and visual analogue scale (VAS)] were evaluated. The adverse effects of URSA-S were also recorded. RESULTS The rate of CIS improvement at the end-point was 79.76% and 45.68% in the therapy and placebo groups, respectively (p < 0.05). The fatigue recovery rate of the CIS score and VAS were higher in the therapy (-25.44 ± 18.57, -27.84 ± 2.70) than in the placebo group (-16.59 ± 17.29, -19.46 ± 2.81) (p < 0.05). The difference in fatigue recovery rate between the therapy and placebo groups was significant after 8 weeks. When analysed separately in patients with abnormal liver function tests and fatty liver disease, the fatigue recovery rate of the CIS score and VAS at 8 weeks was higher in the therapy than in the placebo group (p < 0.05). The frequency of adverse events in the therapy group was not significantly higher than that in the placebo group. CONCLUSION URSA-S is effective for alleviating fatigue in patients with liver dysfunction and/or fatty liver. The adverse effects of URSA-S are not significant. This study is registered at https://clinicaltrials.gov/ct2/show/NCT02415777.
Collapse
Affiliation(s)
- B Oh
- Department of Family Medicine, SMG-SNU Boramae Hospital, School of Medicine, Seoul National University, Seoul, Korea
| | - W S Choi
- Department of Family Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
| | - S B Park
- Department of Family Practice and Community Health, Ajou University Hospital, School of Medicine, Ajou University, Suwon, Korea
| | - B Cho
- Department of Family Medicine, Seoul National University Hospital, School of Medicine, Seoul National University, Seoul, Korea
| | - Y J Yang
- Department of Health Promotion Center, Ilsan Paik Hospital, School of Medicine, Inje University, Goyang, Korea
| | - E S Lee
- Department of Health Promotion Center, Ilsan Paik Hospital, School of Medicine, Inje University, Goyang, Korea
| | - J H Lee
- Department of Health Promotion Center, Ilsan Paik Hospital, School of Medicine, Inje University, Goyang, Korea
| |
Collapse
|
38
|
Kim HJ, Lee MH, Lee JE, Park SH, Lee ES, Kang YJ, Lee JH, Shin HN, Kim SI, Im SA, Ahn SH, Lee KS, Sohn J, Han W, Nam SJ. Abstract P1-12-09: The oncologic effect of a gonadotropin releasing hormone (GnRH) agonist for ovarian protection during breast cancer chemotherapy. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p1-12-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Recently, chemotherapy with a GnRH agonist was reported to protect against ovarian failure. This study was aimed at determining the oncologic effect of a GnRH agonist concurrent with chemotherapy for breast cancer patients.
Patients and Methods: A total of 1189 patients aged 20 to 40 years with stage I to III breast cancer who received (neo or adjuvant) chemotherapy from five hospitals in Korea from 2002 to 2012 were reviewed. A gonadotropin releasing hormone (GnRH) agonist was given to 410 patients for ovarian protection during chemotherapy (GnRH agonist group), and 779 patients received chemotherapy without ovarian protection (Chemotherapy alone group). A matching strategy was used to create matched sets of two groups by age, stage, hormone receptor status, Her2/neu status, neo or adjuvant chemotherapy, and institute.
Results: Survival analysis using Cox regression showed that the GnRH agonist group had better distant metastatic-free survival (HR=0.65, 95%CI 0.44-0.97) outcomes but similar disease free survival (HR=0.78, 95% CI 0.57-1.08) compared with the chemotherapy alone group. The survival benefit was significant for hormone receptor positive, Her2/neu negative breast cancer on distant metastasis (HR=0.44, 95% CI 0.20-0.99) and disease free survival (HR0.47 95% CI 0.23-0.93).
Conclusion: Ovarian protection using a GnRH agonist can be safely considered for premenopausal breast cancer patients for whom chemotherapy is planned.
Citation Format: Kim HJ, Lee MH, Lee JE, Park SH, Lee ES, Kang Y-J, Lee JH, Shin HN, Kim SI, Im SA, Ahn SH, Lee KS, Sohn J, Han W, Nam SJ. The oncologic effect of a gonadotropin releasing hormone (GnRH) agonist for ovarian protection during breast cancer chemotherapy. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P1-12-09.
Collapse
Affiliation(s)
- HJ Kim
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - MH Lee
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - JE Lee
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - SH Park
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - ES Lee
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - Y-J Kang
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - JH Lee
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - HN Shin
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - SI Kim
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - SA Im
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - SH Ahn
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - KS Lee
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - J Sohn
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - W Han
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| | - SJ Nam
- Division of Breast and Endocrine, College of Medicine, University of Ulsan, Asan Medical Center; Seoul National University College of Medicine, Seoul; Division of Breast and Endocrine Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; Yonsei University College of Medicine, Seodaemun-gu, Seoul, Korea; Cancer Biostatistics Branch, Research Institute for National Cancer Control and Evaluation, Research Institute and Hospital, National Cancer Center, Goyang, Korea; Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea; Seoul National University College of Medicine; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Division of Medical Oncology, Yonsei University College of Medicine
| |
Collapse
|
39
|
Sim SH, Bae CD, Kwon Y, Park IH, Lee KS, Jung SY, Lee S, Kang HS, Lee ES, Kim HS, Hong KM, Ro J. Abstract P5-08-25: CKAP2 (cytoskeleton associated protein 2) is a new prognostic marker in HER2-negative luminal breast cancer. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p5-08-25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Ki-67 has been increasingly used as a prognostic marker in spite of debates on the evaluation methods and inconsistent results on its clinical values. CKAP2 is a microtubule-associated protein which plays key roles in microtubule assembly and disassembly. In the present study, the clinical significance of CKAP2-positive cells was evaluated and compared with the results of Ki-67 positive cells.
Methods: A total of 579 early breast cancer patients who underwent surgery at the National Cancer Center Hospital between 2001 and 2005 were accrued. The proliferation activity was measured by CKAP2-positive cell count (CPCC) and Ki-67 labeling index (Ki-67 LI) using CKAP2 and Ki-67 antibodies, respectively, by immunohistochemcial staining on FFPE tumor tissue. The correlation of CPCC or Ki-67 LI with recurrence free survival (RFS) was analyzed. The immunofluorescent staining was performed on HeLa cells after synchronization by double thymidine block to compare the patterns between CKAP2 and Ki-67.
Results: The CPCC (median, 8 with the range of 0- 170) and Ki-67 LI (median, 10.2 with the range of 0%- 91.7%) were highly correlated (R = 0.754, P < 0.001). While CPCC was marginally significant in multivariate analysis for RFS in all cases, it was a significant variable for RFS in the subset analysis with HER2-negative luminal breast cancer patients (HR, 3.154; 95% CI, 1.154-10.693; P = 0.027). On the contrary, Ki-67 LI failed to show any correlation with RFS in all or any subgroups. In the analysis on HeLa cells, CKAP2 staining was more specific to cells in metaphase than Ki-67 staining.
Conclusions: CPCC can be an independent prognostic factor specifically in a HER2-negative luminal type of breast cancer. In addition, CPCC appears to be superior to Ki-67 LI as a survival indicator which may be related to the restricted expression pattern of CKAP2 in metaphase cells. Further study is warranted.
Citation Format: Sim SH, Bae C-D, Kwon Y, Park IH, Lee KS, Jung S-Y, Lee S, Kang H-S, Lee ES, Kim H-S, Hong K-M, Ro J. CKAP2 (cytoskeleton associated protein 2) is a new prognostic marker in HER2-negative luminal breast cancer. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P5-08-25.
Collapse
Affiliation(s)
- SH Sim
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - C-D Bae
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - Y Kwon
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - IH Park
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - KS Lee
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - S-Y Jung
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - S Lee
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - H-S Kang
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - ES Lee
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - H-S Kim
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - K-M Hong
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| | - J Ro
- Center for Breast Cancer, National Cancer Center, Goyang, Korea; Research Institute, National Cancer Center, Goyang, Korea; Sungkyunkwan University School of Medicine, Suwon, Korea; Inje University Ilsan Paik Hospital, Goyang, Korea
| |
Collapse
|
40
|
Lee MH, Park B, Song EJ, Park SJ, Kong SY, Lee ES. Abstract P4-10-12: Psychosocial health of disease-free breast cancer survivors compared with cancer-free general population: Korean health examinee cohort study. Cancer Res 2016. [DOI: 10.1158/1538-7445.sabcs15-p4-10-12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background/purpose: The number of long-term breast cancer survivors is increasing rapidly due to the growing rates of detection, incidence and improved survival. Quality of life (QOL) of physical and psychosocial health outcomes vary across the breast cancer survivors including diagnosis at different stages of breast cancer. There is little data regarding the psychosocial health of disease-free breast cancer survivors compared with those of general population. We conducted to assess the QOL, especially psychosocial health, of disease-free female survivors over 2 year after breast cancer diagnosis compared with cancer-free control women.
Methods: We used baseline data from the health examinee cohort, a part of the Korea Genome Epidemiology Study which is a large scaled cohort study established since 2001. This cohort has collected data of past medical history, socioeconomical factors (income, education, marital status and current employment status) and health behavioral factors (smoking, drinking, physical activity, BMI, menopausal status and subjective health status) of participants while they underwent regular health examination. The disease-free breast cancer survivors were defined as those who answered that they were ≥2 years from the initial diagnosis of breast cancer without recurrence and current treatment. Among the participants female subjects without history of any type cancer were randomly selected at 1:4 ratio by 5-year age groups, educational attainment level and household income as a comparison group. We analyzed Psychosocial Well-being Index-Short Form (PWI-SF) in these two groups. Subjects with score ≤8, 9–26, and 27 were classified as the 'healthy group', 'latent stress group', and 'stress group,' respectively.
Results: Total 347 survivors of breast cancer and 1,388 matched participants without cancer history were selected for analysis. Even after being matched for education and household income status, breast cancer survivors showed better psychosocial health status and health behaviors compared with matched comparison group. The prevalence of latent stress and stress group (vs healthy group) by PWI-SF score was 88.2% in breast cancer survivors and 89.9% in the matched female controls, showing borderline significant differences (p = 0.057). The prevalence rates of ever drinkers and smokers or obese women were lower and of those who exercised ≥150 min/week were higher in breast cancer survivors (p < 0.05). The total PWI-SF score was lower in breast cancer survivors, suggesting lower level of psychosocial stress level in breast cancer survivors. After adjusting for effects of other sociodemographic variables, breast cancer survivors were less likely to be included in stress group by 36% (OR = 0.64; 95% confidence interval [CI], 0.42–0.98).
Conclusions: The disease-free breast cancer survivors with regular health examination showed better psychosocial health status compared with matched general population. The better health behaviors in cancer survivors such as less alcohol drinking, low BMI, less history of smoking and more regular exercise, which have been identified in several previous cancer survivors studies might be attributed to their better psychosocial health status.
Citation Format: Lee MH, Park B, Song EJ, Park SJ, Kong S-Y, Lee ES. Psychosocial health of disease-free breast cancer survivors compared with cancer-free general population: Korean health examinee cohort study. [abstract]. In: Proceedings of the Thirty-Eighth Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2015 Dec 8-12; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2016;76(4 Suppl):Abstract nr P4-10-12.
Collapse
Affiliation(s)
- MH Lee
- Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
| | - B Park
- Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
| | - EJ Song
- Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
| | - SJ Park
- Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
| | - S-Y Kong
- Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
| | - ES Lee
- Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
| |
Collapse
|
41
|
Lee ES, Jung SY, Kim JY, Kim JJ, Yoo TK, Kim YG, Lee KS, Lee ES, Kim EK, Min JW, Han W, Noh DY, Moon HG. Identifying the potential long-term survivors among breast cancer patients with distant metastasis. Ann Oncol 2016; 27:828-33. [PMID: 26823524 DOI: 10.1093/annonc/mdw036] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2015] [Accepted: 01/15/2016] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND We aimed to develop a prediction model to identify long-term survivors after developing distant metastasis from breast cancer. PATIENTS AND METHODS From the institution's database, we collected data of 547 patients who developed distant metastasis during their follow-ups. We developed a model that predicts the post-metastasis overall survival (PMOS) based on the clinicopathologic factors of the primary tumors and the characteristics of the distant metastasis. For validation, the survival data of 254 patients from four independent institutions were used. RESULTS The median duration of the PMOS was 31.0 months. The characteristics of the initial primary tumor, such as tumor stage, hormone receptor status, and Ki-67 expression level, and the characteristics of the distant metastasis presentation including the duration of disease-free interval, the site of metastasis, and the presence of metastasis-related symptoms were independent prognostic factors determining the PMOS. The association between tumor stage and the PMOS was only seen in tumors with early relapses. The PMOS score, which was developed based on the above six factors, successfully identified patients with superior survival after metastasis. The median PMOS for patients with a PMOS score of <2 and for patients with a PMOS score of >5 were 71.0 and 12 months, respectively. The clinical significance of the PMOS score was further validated using independent multicenter datasets. CONCLUSIONS We have developed a novel prediction model that can classify breast cancer patients with distant metastasis according to their survival after metastasis. Our model can be a valuable tool to identify long-term survivors who can be potential candidates for more intensive multidisciplinary approaches. Furthermore, our model can provide a more reliable survival information for both physicians and patients during their informed decision-making process.
Collapse
Affiliation(s)
- E S Lee
- Department of Surgery, Seoul National University College of Medicine, Laboratory of Breast Cancer Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul
| | - S Y Jung
- Center for Breast Cancer, National Cancer Center, Goyang
| | - J Y Kim
- Department of Surgery, College of Medicine, Gyeongsang National University, Jinju
| | - J J Kim
- Department of Surgery, Seoul National University College of Medicine, Laboratory of Breast Cancer Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul
| | - T K Yoo
- Department of Surgery, Seoul National University College of Medicine, Laboratory of Breast Cancer Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul
| | - Y G Kim
- Department of Surgery, Seoul National University College of Medicine, Laboratory of Breast Cancer Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul
| | - K S Lee
- Center for Breast Cancer, National Cancer Center, Goyang
| | - E S Lee
- Center for Breast Cancer, National Cancer Center, Goyang
| | - E K Kim
- Department of Surgery, Breast Cancer Center, Seoul National University Bundang Hospital, Seongnam
| | - J W Min
- Department of Surgery, Dankook University College of Medicine, Cheonan, Korea
| | - W Han
- Department of Surgery, Seoul National University College of Medicine, Laboratory of Breast Cancer Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul
| | - D Y Noh
- Department of Surgery, Seoul National University College of Medicine, Laboratory of Breast Cancer Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul
| | - H G Moon
- Department of Surgery, Seoul National University College of Medicine, Laboratory of Breast Cancer Biology, Cancer Research Institute, Seoul National University College of Medicine, Seoul
| |
Collapse
|
42
|
Jung YJ, Melencion SMB, Lee ES, Park JH, Alinapon CV, Oh HT, Yun DJ, Chi YH, Lee SY. Universal Stress Protein Exhibits a Redox-Dependent Chaperone Function in Arabidopsis and Enhances Plant Tolerance to Heat Shock and Oxidative Stress. Front Plant Sci 2015; 6:1141. [PMID: 26734042 PMCID: PMC4685093 DOI: 10.3389/fpls.2015.01141] [Citation(s) in RCA: 51] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/25/2015] [Accepted: 12/01/2015] [Indexed: 05/20/2023]
Abstract
Although a wide range of physiological information on Universal Stress Proteins (USPs) is available from many organisms, their biochemical, and molecular functions remain unidentified. The biochemical function of AtUSP (At3g53990) from Arabidopsis thaliana was therefore investigated. Plants over-expressing AtUSP showed a strong resistance to heat shock and oxidative stress, compared with wild-type and Atusp knock-out plants, confirming the crucial role of AtUSP in stress tolerance. AtUSP was present in a variety of structures including monomers, dimers, trimers, and oligomeric complexes, and switched in response to external stresses from low molecular weight (LMW) species to high molecular weight (HMW) complexes. AtUSP exhibited a strong chaperone function under stress conditions in particular, and this activity was significantly increased by heat treatment. Chaperone activity of AtUSP was critically regulated by the redox status of cells and accompanied by structural changes to the protein. Over-expression of AtUSP conferred a strong tolerance to heat shock and oxidative stress upon Arabidopsis, primarily via its chaperone function.
Collapse
|
43
|
Ahn JI, Lee ST, Park JH, Kim JY, Park JH, Choi JK, Lee G, Lee ES, Lim JM. In vitro-growth and Gene Expression of Porcine Preantral Follicles Retrieved by Different Protocols. Asian-Australas J Anim Sci 2014; 25:950-5. [PMID: 25049649 PMCID: PMC4092981 DOI: 10.5713/ajas.2010.10355] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/04/2010] [Revised: 07/26/2011] [Accepted: 12/08/2010] [Indexed: 12/03/2022]
Abstract
This study was conducted to determine how the isolation method of the porcine preantral follicles influenced the following follicular growth in vitro. Mechanical and enzymatical isolations were used for retrieving the follicles from prepubertal porcine ovaries, and in vitro-growth of the follicles and the expression of folliculogenesis-related genes were subsequently monitored. The enzymatic retrieval with collagenase treatment returned more follicles than the mechanical retrieval, while the percentage of morphologically normal follicles was higher with mechanical retrieval than with enzymatic retrieval. After 4 days of culture, mechanically retrieved, preantral follicles yielded more follicles with normal morphology than enzymatically retrieved follicles, which resulted in improved follicular growth. The mRNA expression of FSHR, LHR Cx43, DNMT1 and FGFR2 genes was significantly higher after culture of the follicles retrieved mechanically. These results suggest that mechanical isolation is a better method of isolating porcine preantral follicles that will develop into competent oocytes in in vitro culture.
Collapse
Affiliation(s)
- J I Ahn
- Department of Animal Biotechnology, Kangwon National University, Chunchon 200-701, Korea
| | - S T Lee
- Department of Animal Biotechnology, Kangwon National University, Chunchon 200-701, Korea
| | - J H Park
- Department of Animal Biotechnology, Kangwon National University, Chunchon 200-701, Korea
| | - J Y Kim
- School of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chunchon 200-701, Korea
| | - J H Park
- Department of Animal Biotechnology, Kangwon National University, Chunchon 200-701, Korea
| | - J K Choi
- Department of Animal Biotechnology, Kangwon National University, Chunchon 200-701, Korea
| | - G Lee
- School of Dentistry, Seoul National University, Seoul 110-742, Korea
| | - E S Lee
- School of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chunchon 200-701, Korea
| | - J M Lim
- Department of Animal Biotechnology, Kangwon National University, Chunchon 200-701, Korea
| |
Collapse
|
44
|
Chae SY, Lee ES, Jung H, Hwang YJ, Joo OS. Synthesis of Bi2WO6 photoanode on transparent conducting oxide substrate with low onset potential for solar water splitting. RSC Adv 2014. [DOI: 10.1039/c4ra02868f] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
High conduction band of Bi2WO6, thus low onset potential of Bi2WO6/Co-Pi photoanode, is favourable for overall water splitting at zero bias potential when it combines with a silicon photocathode.
Collapse
Affiliation(s)
- Sang Youn Chae
- Clean Energy Research Center
- Korea Institute of Science and Technology (KIST)
- Seoul 136-791, Republic of Korea
- Department of Chemistry
- College of Science
| | - Eun Seon Lee
- Clean Energy Research Center
- Korea Institute of Science and Technology (KIST)
- Seoul 136-791, Republic of Korea
| | - Hyejin Jung
- Clean Energy Research Center
- Korea Institute of Science and Technology (KIST)
- Seoul 136-791, Republic of Korea
- Department of Clean Energy and Chemical Engineering
- Korea University of Science and Technology
| | - Yun Jeong Hwang
- Clean Energy Research Center
- Korea Institute of Science and Technology (KIST)
- Seoul 136-791, Republic of Korea
- Department of Clean Energy and Chemical Engineering
- Korea University of Science and Technology
| | - Oh-Shim Joo
- Clean Energy Research Center
- Korea Institute of Science and Technology (KIST)
- Seoul 136-791, Republic of Korea
| |
Collapse
|
45
|
Song HR, Park HS, Yun KE, Cho SH, Choi EY, Lee SY, Kim JH, Sung HN, Kim JH, Choi SI, Yoon YS, Lee ES, Han JH, Shin CI, Chang HM, Bae SC. Gender and age differences in the impact of overweight on obesity-related quality of life among Korean adults. Obes Res Clin Pract 2013; 4:e1-e82. [PMID: 24345622 DOI: 10.1016/j.orcp.2009.07.003] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2008] [Revised: 07/17/2009] [Accepted: 07/21/2009] [Indexed: 10/20/2022]
Abstract
SUMMARY OBJECTIVE To investigate gender and age difference in impact of overweight on health-related quality of life (HRQOL) among Korean adults. METHODS Cross-sectional obesity-related quality of life (QOL) scores were measured by a Korean obesity-related QOL scale (KOQOL) from 448 Korean adults aged 20-80 years. A body mass index (BMI) was categorized with normal-weight as BMI < 23 kg/m(2), overweight as BMI ≥ 23 kg/m(2) based on the alternative cutoff points for Asians. Each gender was respectively stratified by median age, 45 years for men and 50 years for women, to examine the obesity-related QOL by age groups. RESULTS Women had a poorer obesity-related QOL compared to men (p < 0.001). In the younger age group, overweight women had a poorer obesity-related QOL compared with normal-weight women (p < 0.001), however normal-weight and overweight men showed no difference in obesity-related QOL. In the older age group, overweight men showed better QOL on the domains of work-related and psychosocial health than those for normal-weight men, but overweight women still suffered from work-related and routine life QOL. CONCLUSIONS This study showed the impact of overweight on obesity-related QOL was different for gender and age group. We should consider the results to manage weight in overweight persons.
Collapse
Affiliation(s)
- H R Song
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - H S Park
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea.
| | - K E Yun
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - S H Cho
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - E Y Choi
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - S Y Lee
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - J H Kim
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - H N Sung
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - J H Kim
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - S I Choi
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - Y S Yoon
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - E S Lee
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - J H Han
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - C I Shin
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - H M Chang
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| | - S C Bae
- Department of Internal Medicine, Hanyang University College of Medicine, South Korea
| |
Collapse
|
46
|
You JY, Song EJ, Lee MH, Jung SY, Lee SY, Kang HS, Lee ES. Abstract P1-01-19: Role of axillary clearance with tumor positive sentinel node in mastectomy group: Is the results of ACOSOG Z0011 trial adaptable to mastectomy patient? Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p1-01-19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Recent data from ACOSOG Z0011 trial or AMAROS trial suggest that axillary lymph node dissection(ALND) may be unnecessary for patients with positive sentinel lymph node biopsy(SLNB) receiving breast conserving surgery(BCS) with irradiation. However, consensus statements and guidelines until recently recommended that patients with mastectomy and tumor positive sentinel node undergo completion ALND. In this preliminary study, we compared these patients who did not undergo ALND with the patients who received BCS with SLNB only and irradiation and we analyzed the locoregional recurrence rate to show no differences of outcomes between two groups.
Method: We identified 6,163 women with invasive breast cancer who underwent surgical resection at the National Cancer Center (Goyang,Gyeonggi-do,Korea) between January 2000 to December 2011. Clinico-pathological data obtained from prospective collecting medical database of our institution were analyzed retrospectively. The mastectomy with positive SLNB group was 47 patients and BCS with positive SLNB and irradiation group was 172 patients. The primary end point was loco-regional recurrence rate.
Result : Clinical and tumor characteristics were similar between two groups except T stage and receptor status. The mean tumor size was 5.5cm with mastectomy group and 3.5cm with BCS group. The median number of nodes removed was three. There was not a single case of locoregional recurrence in both groups. At a median follow-up of 53.5 months (last follow-up, May 2013), 5-year overall survival was 85.7% with mastectomy and 97.3% with BCS group.
Conclusion : In our study, there was no case of locoregional recurrence as above. This results lend weight to the argument that SLNB without ALND may be reasonable management for selected patients with appropriate surgery and adjuvant systemic therapy. This study can be regarded as a preliminary study with a sufficient value despite of the prognosis showed some statistical differences between two groups. It resides in the difference of initial stage of patients of two groups. We will present additional data compared with the mastectomy with axillary clearance group at the meeting.
Acknowledgement This work was supported by grant from the National Cancer Center Korea (1210331-2).
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P1-01-19.
Collapse
Affiliation(s)
- JY You
- Center for Breast Cancer, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - EJ Song
- Center for Breast Cancer, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - MH Lee
- Center for Breast Cancer, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - SY Jung
- Center for Breast Cancer, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - SY Lee
- Center for Breast Cancer, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - HS Kang
- Center for Breast Cancer, National Cancer Center, Goyang, Gyeonggi-do, Korea
| | - ES Lee
- Center for Breast Cancer, National Cancer Center, Goyang, Gyeonggi-do, Korea
| |
Collapse
|
47
|
Lee ES, Lundberg TM, Ley MB, Waer A, Livingston RB, Stopeck AT, Chalasani P, Gonzalez VJ, LeBeau LG, Rose JF, Viscusi RK. Abstract P1-12-03: Primary squamous cell carcinoma of the breast. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p1-12-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
BACKGROUND: Primary squamous cell carcinoma of the breast (PSCCB) is one of the rarest forms of breast cancer, accounting for less than 0.1% of all breast cancers. PSCCB can be aggressive with no typical radiologic findings on mammogram, often leading to delays in diagnoses or missed diagnoses. Previously reported cases of PSCCB have illustrated a wide range of clinical presentations, from an abnormal mammogram with no obvious breast mass to a breast abscess. In addition, due to the rarity of this disease, no clear consensus on definitive treatment or prognosis exists.
METHODS: Using a search of our pathology database, we identified females diagnosed with PSCCB at our institution from 2007-2012. Inclusion criteria included female patients over the age of 18 years old with a primary tumor consisting of >90% malignant cells of squamous origin. Likewise, exclusion criteria included squamous cell cancer that had metastasized to the breast from elsewhere or lesions that were not independent of the overlying skin or nipple. We then performed a retrospective review to evaluate patient characteristics, presentation, tumor characteristics, treatment modalities and outcomes.
RESULTS: We identified three patients who were diagnosed with PSCCB during that timeframe. Their ages ranged from 35-65 years old, with two being post-menopausal and one pre-menopausal. Of the three, two were Caucasian and one was Hispanic. All three presented after self-palpating a breast mass. The average size of the mass seen on mammogram was 2.9 cm (range of 2.4 to 3.6 cm). Histologically, all three of the cancers were moderately to poorly differentiated. In addition, they all had a negative estrogen, progesterone, and HER2 receptor status with an elevated Ki-67. One patient was diagnosed at our institution but did not proceed to surgery and was lost to follow up. For the other two patients, one chose to undergo breast conservation with partial mastectomy and sentinel lymph node biopsy followed by whole breast radiation. The second patient proceeded with a total mastectomy and sentinel lymph node biopsy without radiation. There was no evidence of regional nodal disease in either patient at time of surgery. Furthermore, neither patient received any systemic therapy. Both patients were disease free at last follow up which was 5 and 11 months respectively.
CONCLUSION: Because PSCCB is so rare, prognosis and optimal treatment are still controversial. Most of the current literature portrays PSCCB as an aggressive cancer with a poor prognosis. This often leads to multimodality therapy consisting of mastectomy with axillary nodal clearance, adjuvant chemotherapy and radiation. In addition, locoregional and distant recurrences are common despite this aggressive treatment leading to the conclusion that PSCCB is relatively radioresistant with limited activity seen when using conventional breast cancer systemic therapies. Because treatment options can be limited, more research is needed to further elucidate the biological behavior of this rare cancer as well prognostic factors that may allow us to treat a patient more conservatively.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P1-12-03.
Collapse
Affiliation(s)
- ES Lee
- University of Arizona Health Network, Tucson, AZ
| | - TM Lundberg
- University of Arizona Health Network, Tucson, AZ
| | - MB Ley
- University of Arizona Health Network, Tucson, AZ
| | - A Waer
- University of Arizona Health Network, Tucson, AZ
| | | | - AT Stopeck
- University of Arizona Health Network, Tucson, AZ
| | - P Chalasani
- University of Arizona Health Network, Tucson, AZ
| | - VJ Gonzalez
- University of Arizona Health Network, Tucson, AZ
| | - LG LeBeau
- University of Arizona Health Network, Tucson, AZ
| | - JF Rose
- University of Arizona Health Network, Tucson, AZ
| | - RK Viscusi
- University of Arizona Health Network, Tucson, AZ
| |
Collapse
|
48
|
Kim MK, Moon HG, Kim J, Lee JW, Kim J, Lee ES, Yoo TK, Noh DY, Han W. Abstract P3-14-20: Neoadjuvant chemotherapy in young age breast cancer: Survival benefit over adjuvant chemotherapy in clinically T2 node positive patients. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p3-14-20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: The downstaging of the primary tumor and the increase in breast conservation rates seems to be the only clinical benefit of Neoadjuvant systemic therapy(NST) in breast cancer treatment, given that several studies failed to demonstrate an improvement of overall survival compared with postoperative adjuvant chemotherapy. In Europe, S6 trial showed better early outcome in survival in favour of the neoadjuvant chemotherapy group compared to adjuvant chemotherapy group in premenopausal patients without significantly modifying long-term event rates. The aim of this study was to assess a potential advantage in survival by neoadjuvant as compared to adjuvant chemotherapy in young age breast cancer patients.
Methods: Between January 2001 and December 2008, 1169 consecutive patients with breast cancer aged under 40 underwent adjuvant chemotherapy before or after surgery. Prospectively collected medical records for all patients were reviewed retrospectively. For the comparison of survival between neoadjuvant versus adjuvant chemotherapy group, cinically T2 and node positive patients were retrieved. Survival curves were derived from Kaplan-Meier estimates and compared by log-rank test.
Results: Of the 1169 patients, 203(17.3%) patients were treated with neoadjuvant chemotherapy, and they were grouped as ‘NST’ and ‘non-NST’ according to initial treatment. About 47% patients in each group were clinically T2 patients. (99(47.8%) in NST group, 453(46.9%) in non-NST group) Among them, clinically T2 and node positive patients were 188, 97 patients in NST group, 91 patients in non-NST group each. The median age was 35.11±3.9 years old and HER2 amplification was observed as 23.5%, and they were not different between two groups.(p = 0.146 and 0.941 each) Significant lower hormone receptor expression rate and higher Ki-67 level were observed in NST group(p = 0.03 and <0.0001 each) Breast conservation surgery rate was also significantly different between two groups, more favorable results in NST group.(67% in NST group, 37.4% in non-NST group, p<0.0001) During median follow-up period of 61 months (range 44 to 148 months), we observed a statistically significant difference (p = 0.011) in survival in favour of the NST group. This benefit of survival was presented consistently regardless of hormone receptor expression. A similar trend was seen when the time to distant disease recurrence was evaluated (p = 0.176). And this trend was more prominent in hormone receptor negative patients, but still not statistically significant. (p = 0.144) The mean total dose of chemotherapy administered was similar in both groups. Improved survival figures in the NST group could be the result of the early initiation of systemic treatment, but the trend in favour of decreased metastases was not statistically significant.
Conclusion: A potential advantage of primary over adjuvant chemotherapy in young age breast cancer patients’ survival might be proposed by this results.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P3-14-20.
Collapse
Affiliation(s)
- MK Kim
- Seoul National University Hospital, Seoul, Korea
| | - H-G Moon
- Seoul National University Hospital, Seoul, Korea
| | - J Kim
- Seoul National University Hospital, Seoul, Korea
| | - JW Lee
- Seoul National University Hospital, Seoul, Korea
| | - J Kim
- Seoul National University Hospital, Seoul, Korea
| | - ES Lee
- Seoul National University Hospital, Seoul, Korea
| | - T-K Yoo
- Seoul National University Hospital, Seoul, Korea
| | - D-Y Noh
- Seoul National University Hospital, Seoul, Korea
| | - W Han
- Seoul National University Hospital, Seoul, Korea
| |
Collapse
|
49
|
Kim MK, Moon HG, Kim J, Lee JW, Yoo TK, Kim J, Lee ES, Noh DY, Han W. Abstract PD4-2: Whole exome and transcriptome sequencing of 120 primary breast cancer to discover novel therapeutic target. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-pd4-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Many somatic mutations, structural alterations, and gene expression changes are causally implicated in oncogenesis and tumor progression, and as a result, affect clinical outcome. Although majority of breast cancer patients have benefits from therapeutics targeting tumor biology, such as estrogen receptor and HER-2, still many patients suffer from disease recurrence and metastasis. More kind of specific target therapies are needed, especially for hormone-resistant tumor and triple-negative breast cancer.
Materials and Method: To find novel therapeutic target in breast cancer, here we examine the both whole exome and whole transcriptome of fresh-frozen primary breast cancer tissues from 120 patients whose clinical, pathological, and survival data are available. Patients with Stage IV disease or who received neoadjuvant chemotherapy were excluded. 36 patients had distant metastasis within 5 years from surgery, and 84 patients were NED at least 5 years. RNA and DNA were extracted and qualities were assessed in all samples. Exome and transcriptome sequencing were done using NGS technology (Illumina HiSeq 2000). As a control, exome sequencing was done for 93 normal DNA from matched patients. Single nucleotide variations (SNV) identified in cancer samples on exonic region, nonsynonymous SNV or stop gain/loss, whose quality ≥20, and not found in 93 normal samples were included. SNVs registered in dbSNP135_common or 1000 genome allele frequency >0.001 were excluded.Results and Discussion: We identified 11,684 putative somatic mutations in 7,373 genes. Of them, 6,547 were deleterious or damaging mutation by Provean or SIFT analysis. Mutations were found in potential drug target genes, such as PIK3CA(25), PTEN(3), AKT1(3), ALK(3), ROS1(2), FGFR4(3), FGFR3(2), ERBB2(2), and IDH1(1) etc. In a pathway analysis, mutations in insulin signaling pathway were most dominant. We hypothesized that driver gene and therapeutic target has to have recurrent mutation and gene expression at least more than average expression. We calculated expression “Volume” according to the median normalized FPKM value of individual gene's RNA-seq data. With a cut-off of 3 or more mutations in each gene, 1,116 genes were selected. After the filtering of Volume<0.3, 696 genes were selected. Finally, 55 genes were selected which are druggable or potentially druggable using drug database (DrugBank, TOCRIS, Ingenuity) and Pubmed. DriverNet analysis result was also considered for the selection. All 342 tumor suppressor genes were filtered out. Interestingly, 18 of the 55 were genes involved in metabolism (fatty acid, glucose, amino acids). 12 were kinases and 4 were involved in insulin pathway. Excluding the previously confirmed therapeutic target, PIK3CA, AKT1, and NOTCHs, and considering the patients’ clinical data, our primary candidates for hormone-resistant breast cancer were NQO2, CELSR1, GLUD2, MYH9, PSMD2, NADK, IRS2, MAP3K5, and for triple-negative breast cancer were HSPG2, PHGDH, MYLK, etc. Validation with Sanger sequencing and functional study is on-going.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr PD4-2.
Collapse
Affiliation(s)
- MK Kim
- Seoul National University Hospital, Seoul, Korea
| | - H-G Moon
- Seoul National University Hospital, Seoul, Korea
| | - J Kim
- Seoul National University Hospital, Seoul, Korea
| | - JW Lee
- Seoul National University Hospital, Seoul, Korea
| | - T-K Yoo
- Seoul National University Hospital, Seoul, Korea
| | - J Kim
- Seoul National University Hospital, Seoul, Korea
| | - ES Lee
- Seoul National University Hospital, Seoul, Korea
| | - D-Y Noh
- Seoul National University Hospital, Seoul, Korea
| | - W Han
- Seoul National University Hospital, Seoul, Korea
| |
Collapse
|
50
|
Lee ES, Park BR, Kim A, Choi CH, Kim HY. RETRACTED: Different bone mineral density in cervical and endometrial cancer. Climacteric 2013:1-6. [PMID: 24138177 DOI: 10.3109/13697137.2013.850479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Objectives Patients with cervical cancer have lower bone mass than women without cancer, whereas women with endometrial cancer have higher bone mineral density (BMD) than control subjects, possibly due to the prevalence of high body-fat mass. The aim of this study was to compare BMD in patients with cervical cancer, endometrial cancer and controls. Methods We analyzed and compared spinal and femoral BMD in 130 patients with cervical cancer, 68 with endometrial cancer, and 140 age-matched menopausal female control subjects. We also compared serum calcium, phosphorus, total alkaline phosphatase, osteocalcin, and urinary deoxypyridinoline levels. Results Compared with the control group, T-scores for some lumbar vertebrae (L4), the femoral neck, and Ward's triangle were lower in patients with cervical cancer, whereas only L4 T-scores were significantly lower in patients with endometrial cancer. Deoxypyridinoline levels were significantly lower in women with endometrial cancer (p < 0.002) than in women with cervical cancer, but no other biochemical variables differed among groups. Conclusions Cervical cancer was associated with lower BMD, especially in femoral BMD, and may be a risk factor for secondary osteoporosis. However, endometrial cancer generally seemed to have no damaging effect on bone except at L4. A further larger follow-up study in more populations is required to clarify these findings.
Collapse
Affiliation(s)
- E S Lee
- Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University , Seoul
| | | | | | | | | |
Collapse
|